Stocks · Conviction
Low conviction · 728 research notes
728 stocks our research rates Low: more likely to lag the S&P 500 over the next three months. Each has a dated research note with its thesis, kill line and next catalyst.
All 728 have a dated research note with a published kill line: the note's own test, stated in advance, of what would prove it wrong: a price level, a business fact, or both.
All stocksAALAmerican Airlines GroupLow American Airlines shares are more likely to lag the S&P 500 over three months because jet fuel near $4.70 a gallon is consuming record revenue; the fourth-quarter report, expected in late January 2027, shows whether the guided loss of…ABCLAbCellera BiologicsLow AbCellera's shares look more likely to lag the S&P 500 over three months, because the case rests on unproven repeat dosing of ABCL635, its monthly hot-flash injectable. The open-label extension data, guided for late 2026 to early 2027,…ACNAccentureLow Accenture's shares are more likely to lag the S&P 500 over the next three months because their $249.95 close on 12 November 2026 already sits above the roughly $230 average analyst target. The fiscal first-quarter 2027 report, expected…ADBEAdobeLow Adobe's shares are more likely to lag the S&P 500 because analysts expect its recurring-revenue growth to slow sharply in fiscal 2027 and its MAX AI launches carry no disclosed revenue. The 9 December report and fiscal 2027 guidance show…ADTLow ADT Inc. trades as a pending $10.00-per-share cash buyout by Thrive Holdings, so its shares are more likely to lag the S&P 500 than lead it. A rival bid before the go-shop window closes on 28 November 2026 is the one event that would…AFRMAffirm HoldingsLow Affirm Holdings' shares are more likely to lag the S&P 500: growth beat in the 5 November 2026 report, but delinquency rose to 2.9% and funding costs climbed. The February 2027 holiday-quarter report shows whether credit steadies.AMATApplied MaterialsLow Applied Materials looks more likely to lag the S&P 500 over the next three months: a 12 November 2026 outlook for more than 30% equipment-industry growth in 2027 did not stop a fall, as 11 brokers cut targets on sector valuations. Nvidia's…AMNAMN Healthcare ServicesLow AMN Healthcare Services is more likely to lag the S&P 500 because its fourth-quarter outlook cuts strike revenue to $5 million from $59 million and resets margins lower; the report expected around February 2027 shows whether nurse staffing…AMPLAmplitudeLow Amplitude's shares are more likely to lag the S&P 500: its 4 November 2026 beat-and-raise left net retention flat at 103% and gross margin lower, and the shares fell the next day. The fourth-quarter report, expected in February 2027,…ARMArm HoldingsLow Arm Holdings shares look more likely to lag the S&P 500 because royalty growth slowed to 8% and is guided to low single digits. Judge Noreika's ruling on Qualcomm's royalty suspension and the report due in early February 2027 settle the…ARRYArray TechnologiesLow Array Technologies' shares are more likely to lag the S&P 500 while they trade on the all-stock Shoals merger after a cut to 2026 guidance; the S-4 filing, both shareholder votes and a first-quarter-2027 closing decide whether the $2.2–2.4…ASMLASML HoldingLow ASML Holding's shares look more likely to lag the S&P 500 than lead it while chip stocks reprice 2027 US data-centre spending risk, despite supply that trails demand through 2028. Nvidia's 17 November 2026 report and ASML's late-January…ASTSAST SpaceMobileLow AST SpaceMobile's shares look more likely to lag the S&P 500 than lead it after a third-quarter revenue miss and a 45-satellite target pushed to mid-2027. Shipment of BlueBirds 17 to 19 by the end of November 2026 and launches of BlueBirds…AXPAmerican ExpressLow American Express shares are more likely to lag the S&P 500 over the next three months, as card spending growth slowed to 8% and the 2026 guidance raise rests on a one-time gain; the fourth-quarter report and 2027 outlook, expected in late…AZOAutoZoneLow AutoZone is more likely to lag the S&P 500 over three months: its 1.6% domestic same-store sales growth trails O'Reilly's 7.2%, and its latest profit gain leaned on tariff refunds. The 8 December 2026 first-quarter report shows whether…BABoeingLow Boeing's shares look more likely to lag the S&P 500 because 737 MAX deliveries fell to 32 in October 2026 and its airplane unit is cutting 5% of staff. The November delivery release (~8 December 2026) and 777X engine-seal and ETOPS…BABAAlibaba Group HoldingLow Alibaba's shares are more likely to lag the S&P 500 into the 19 November 2026 September-quarter report: cloud revenue grew 45% in the June quarter, but chip supply, Qwen pricing and funding costs are unresolved. The report shows whether…BACBank of AmericaLow Bank of America's shares look more likely to lag the S&P 500 as weak fees and trading, a $1.2 billion penalty and falling broker targets outweigh 8% lending-income growth; the 15 January 2027 fourth-quarter report shows whether fees…BBWIBath & Body WorksLow Bath & Body Works shares are more likely to lag the S&P 500 because analysts already expect third-quarter earnings above the company's own guidance; the 19 November 2026 Q3 report settles whether sales and the roughly $650 million…BEBloom EnergyLow Bloom Energy shares look more likely to lag the S&P 500 over three months: the 11 November rebound followed CoreWeave's results, while Oracle's 2.4 GW Project Jupiter still lacks its New Mexico air permit. The hearing that opens 7 December…BETABeta TechnologiesLow Beta Technologies' shares look more likely to lag the S&P 500, because Jefferies now models first CX300 deliveries in 2028 and fourth-quarter revenue is guided below the third quarter's. The FAA's pilot-program pathway and the early-2027…BETRBetter Home & Finance HoldingLow Better Home & Finance shares are more likely to lag the S&P 500 over three months: volume fell from $496 million in July to $345 million in October and cash is shrinking. The weekly Better 2.0 scorecards will show whether the cost cuts…BIDUBaiduLow Baidu's shrinking search advertising still outweighs its fast-growing AI cloud, so the ADS is more likely to lag the S&P 500 over three months; the third-quarter report on 16 November 2026 shows whether the advertising decline narrows.BMBLBumbleLow Bumble's shares are likely to trail the S&P 500 because they trade as a pending $6.05-per-share cash takeover by Ithaca Holdings, closing at $5.99 on 11 November 2026. Antitrust clearance and the Schedule 14C closing timeline decide when…BOBSBobs Discount FurnitureLow Bob's Discount Furniture shares look more likely to lag the S&P 500 as a diesel-driven gross margin cut and a 30% furniture tariff from 1 January 2027 weigh on a stock already near analyst targets. The fourth-quarter report settles whether…BRK.BBerkshire HathawayLow Berkshire Hathaway's class B shares look more likely to lag than lead the S&P 500: third-quarter operating earnings fell 5.8% while the shares hit a record $589.83, far above the $496–$507 Berkshire paid for buybacks. Whether repurchases…BRUNBoost RunLow Boost Run's shares are more likely to lag the S&P 500 over the next three months: third-quarter 2026 revenue missed, a $13 million-a-month Georgia project slipped to 2027, and its 2027 hardware plan far exceeds its cash. The end-November…BRZEBrazeLow Salesforce's agreed $47.50-per-share cash takeover of Braze caps the shares just under the offer, so they are more likely to lag the S&P 500 than lead it over three months. The US antitrust review, the stockholder vote or a rival bid…BSXBoston ScientificLow Boston Scientific shares are more likely to lag the S&P 500 over three months: a cyberattack, falling Watchman sales and lost ablation share turned fourth-quarter sales guidance negative. The fourth-quarter report expected around 4…BZKanzhunLow Kanzhun (BOSS Zhipin) shares are more likely to lag the S&P 500 over three months after an unexplained fall to a record-low $12.49 close on 12 November 2026; the third-quarter 2026 report, expected in late November 2026, shows whether…CAPRCapricor TherapeuticsLow Capricor Therapeutics' shares are more likely to lag the S&P 500 because deramiocel's approval faces an FDA panel that voted 9-3 against its evidence in July 2026. The FDA's action on the narrowed application, due by 22 November 2026,…CARSCars.comLow Cars.com's earnings are growing on cost cuts and buybacks while revenue stays flat, and the shares already trade near analyst targets, so they are more likely to lag the S&P 500 over three months; the late-February 2027 fourth-quarter…CARTMaplebearLow Maplebear, Instacart's parent, looks likely to lag the S&P 500 because DoorDash's $65.00-a-share offer caps the gain while antitrust review may run into 2028. The first federal step on the merger filing settles the case.CATCaterpillarLow Caterpillar's shares look more likely to lag the S&P 500, as political risk to data-center building and margins near the bottom of target outweigh a record $78 billion backlog. The 2027 outlook, expected around 2 February 2027, shows…CCJCamecoLow Cameco's shares are more likely to lag the S&P 500 because record uranium contract prices have not yet reached its earnings, with third-quarter adjusted profit at nil on 30 October 2026. The full-year report expected in February 2027…CDNLCardinal Infrastructure GroupLow Cardinal Infrastructure Group's shares are more likely to lag the S&P 500 over three months after a 4.2% third-quarter margin, withdrawn 2026 guidance and a departing CFO. The fourth-quarter report, expected around March 2027, shows…CERTCertaraLow Certara's software sales have re-accelerated, but at $11.73 the shares already trade near analysts' raised targets, so they are more likely to lag the S&P 500 over the next three months. The fourth-quarter report and 2027 outlook, expected…CHPTChargePoint HoldingsLow ChargePoint shares are more likely to lag the S&P 500 after a 102% three-month rally that outran a business guiding third-quarter revenue below its second quarter. ChargePoint's early-December third-quarter report shows whether revenue and…CLVTClarivateLow Clarivate's shares are more likely to lag the S&P 500 over the next three months: the $533 million debt tender that settled on 13 November 2026 is priced in, and 1.3% organic recurring growth is too slow to lift the stock before the 2027…COINCoinbase GlobalLow Coinbase Global shares look more likely to lag the S&P 500 because trading revenue is shrinking faster than new licenses add income. The fourth-quarter report, expected about mid-February 2027, tests the $550–630 million services guide.COPConocoPhillipsLow ConocoPhillips is more likely to lag the S&P 500 over three months because its gains rest on a war-lifted crude price; the OPEC+ meeting on 29 November 2026 tests that premium.COTYLow Coty Inc.'s debt cut and Q1 FY27 beat have lifted the shares to $4.06, above every analyst target, while earnings are still guided lower; the Consumer Beauty review due by 31 December 2026 decides whether earnings support that price.CRMSalesforceLow Salesforce shares look more likely to lag the S&P 500, as seven acquisitions and S&P's 4 November 2026 credit cut cloud organic growth behind its AI-agent revenue. The 2 December 2026 third-quarter report shows whether cRPO growth beats…CRMDCorMedixLow CorMedix shares are more likely to lag the S&P 500 over three months because its DefenCath drug has lost most of its Medicare premium and 2027 DefenCath guidance is suspended. A separate Medicare Advantage payment deal, which management…CRSPCRISPR TherapeuticsLow CRISPR Therapeutics shares are more likely to lag the S&P 500 over three months: they hit a 52-week closing low of $42.62 on 12 November 2026 despite strong CTX310 data, and December's zugo-cel data at ASH is the next test.CRWDCrowdStrike HoldingsLow CrowdStrike's shares are more likely to lag the S&P 500 over the next three months because at about 156 times forward earnings they already price in fast growth. The 1 December 2026 report settles it by showing whether net new annual…CSCOCisco SystemsLow Cisco Systems' shares look more likely to lag the S&P 500 over three months because product order growth slowed to 21% from 35% despite a raised outlook; the second-quarter report expected in mid-February 2027 shows whether orders recover.CTOCTO Realty GrowthLow CTO Realty Growth is more likely to lag the S&P 500 over three months: per-share earnings are rising, but the shares trade below its 2026 stock-sale price and leverage is climbing; the fourth-quarter report, expected in February 2027,…CTVACortevaLow Corteva, now a pure crop-protection company, is more likely to lag the S&P 500 after cutting its 2026 profit outlook on 11 November 2026 over a materially weaker Brazil. The early-2027 fourth-quarter report and the first 2027 outlook show…CVXChevronLow Chevron's shares are more likely to lag the S&P 500 over the next three months as Brent fell to $91.49 on 10 November 2026 and OPEC output neared prewar levels. The fourth-quarter report, around 30 January 2027, shows whether buybacks rise…CXMSprinklrLow Sprinklr's shares look more likely to lag the S&P 500, because an AI-agent rally has outrun a business whose revenue grew 1% last quarter. The third-quarter report on 2 December 2026 shows whether subscription growth can support the price.DASHDoorDashLow DoorDash shares are more likely to lag the S&P 500 over three months: a $17 billion Instacart deal facing a review that may run to 2028 and a flat fourth-quarter profit guide outweigh record results; the February 2027 report is the next…DEDeereLow Deere & Company is more likely to lag the S&P 500 over three months because its shares already price in a 29% earnings rebound for fiscal 2027; the 25 November 2026 fourth-quarter report and first 2027 outlook show whether the company's…DELLDell TechnologiesLow Dell Technologies' shares look more likely to lag the S&P 500 while AI-spending doubts, data-center politics and memory costs drive the stock; the 24 November 2026 fiscal third-quarter report tests the 15.0% server margin and a $50.63…DISWalt DisneyLow The Walt Disney Company's shares look more likely to trail the S&P 500 than lead it, because a 14.2% three-month gain already prices in parks, streaming and cost-cut gains. The 17 November 2026 fiscal Q4 report shows whether fiscal 2027…DNUTKrispy KremeLow Krispy Kreme's shares are more likely to lag the S&P 500 because its 5 November 2026 earnings beat has not yet turned into cash: free cash flow was negative $10.0 million through nine months and net leverage was 5.5 times. The…DXCDXC TechnologyLow DXC Technology's shares are more likely to lag the S&P 500 because they trade above every post-results analyst target while the insurance-unit sale remains unsigned. A signed deal and its price settle the case.ENGSEnergys GroupLow Energys Group's shares fell 86% in one session to a $0.69 close on 11 November 2026 with no company explanation and are more likely to lag the S&P 500; the delayed fiscal 2026 annual report shows whether a projected 52% revenue gain holds…ENVXEnovixLow Enovix shares are more likely to lag the S&P 500 over three months after the company dropped smartphone field testing and guided fourth-quarter sales below the third quarter's on 12 November 2026. The fourth-quarter report, expected in…ETEnergy Transfer LP Common UnitsLow Energy Transfer's units are more likely to lag the S&P 500 over three months because the raised 2026 outlook rests on commodity gains and one-time items while spending climbs. The fourth-quarter report expected in mid-February 2027, with…FIGRFigure Technology SolutionsLow Figure Technology Solutions shares are more likely to lag the S&P 500 because the company guided its fourth-quarter take rate down to 3.1%–3.4% on 12 November 2026 despite beating forecasts; operating data expected around 7 January 2027…FRMIFermiLow Fermi Inc. shares are more likely to lag the S&P 500 over three months: a $200 million hyperscaler prepayment gives Project Matador a customer, but the 600-megawatt lease is unsigned and the 12 November 2026 10-Q flags going-concern doubt.…FRVOFervo EnergyLow Fervo Energy shares look more likely to lag the S&P 500 over three months: IPO lock-up supply and broker target cuts outweigh an $11.9 billion backlog. Cape Station's GeoBlocks 2 and 3 reaching commercial operation by 1 January 2027 decide…FTREFortrea HoldingsLow Fortrea's shares are more likely to lag the S&P 500: margins are improving, but a $558 million backlog cut clouds 2027 revenue. Backlog growth from $7,316 million at the fourth-quarter report settles the case.GEGE AerospaceLow GE Aerospace shares are more likely to trail the S&P 500 than lead: record China orders lifted them, but services and LEAP delivery growth slowed in the third quarter. FAA approval of the GE9X mid-seal and 2027 guidance around 22 January…GLOBGlobantLow Globant's shares are more likely to lag the S&P 500 because the price has run ahead of flat revenue guidance and Guggenheim downgraded them on 11 November 2026 over weak bookings; the 19 November 2026 third-quarter report shows whether…GOOGAlphabetLow Alphabet's shares are more likely to lag the S&P 500 as 2027 spending above $300 billion and negative free cash flow outweigh Cloud revenue that doubled to $30.7 billion; the fourth-quarter report tests whether the $561 billion Cloud…GOOGLAlphabetLow Alphabet's shares look more likely to lag the S&P 500 because Google Cloud's 103% growth has not yet paid for AI spending that turned free cash flow negative. Anthropic's IPO pricing, expected in the week of 16 November 2026, and the 2027…GRALGRAILLow GRAIL's shares are more likely to lag the S&P 500 over three months: after a 78.8% three-month rise, approval of the Galleri cancer test looks largely priced in while the company cut its 2026 Galleri revenue outlook and per-test prices…GSGoldman Sachs GroupLow Goldman Sachs' shares look more likely to lag the S&P 500 over the next three months: the Anthropic IPO it co-leads is largely priced in, while Fed rate-increase risk and a smaller fee backlog weigh on 2027 fees. The fourth-quarter report,…HALOHalozyme TherapeuticsLow Halozyme Therapeutics' shares are more likely to lag the S&P 500 after two downgrades in a week shifted the debate to royalty-rate step-downs from 2028. The 19 November 2026 German Keytruda SC appeal hearing and 2027 guidance are the next…HAYWHayward HoldingsLow Hayward Holdings' raised 2026 guidance is already priced into shares trading above most broker targets, so they are more likely to lag the S&P 500; the late-February 2027 fourth-quarter report shows whether early-buy orders become sales.HDHome DepotLow Home Depot's shares have climbed on falling mortgage rates while its customer traffic still shrinks, so they look more likely to lag the S&P 500; the 17 November 2026 third-quarter report shows whether guidance and transactions back the…HELEHelen of TroyLow Helen of Troy's shares are more likely to lag the S&P 500 because the $37.98 close on 11 November 2026 already tops Empower Brands' rejected $37.00 offer. A higher signed deal, or a stalemate at the report due around 8 January 2027,…HIMSHims & Hers HealthLow Hims & Hers Health shares are more likely to lag the S&P 500 after a 9 November 2026 report showing 57% gross margin and a flat fourth-quarter revenue guide. November weight-loss billing data and early Lilly drug sales show whether growth…HOODRobinhood MarketsLow Robinhood Markets' event contracts are growing while crypto volume fell 21% in October and stock and options trading stalled, so the shares are more likely to lag the S&P 500; November data and the February 2027 fourth-quarter report…HRIHerc HoldingsLow Herc Holdings looks more likely to lag the S&P 500 over three months because its raised 2026 guide is largely priced in after shares rebounded to $173.90 on 11 November 2026 without new company news. The fourth-quarter report, expected…HUBSHubSpotLow HubSpot shares are more likely to lag the S&P 500: co-founder Brian Halligan's return as CEO on 12 November 2026 left the roughly 12% fourth-quarter growth guide unchanged. The February 2027 report and 2027 outlook settle it.IBMInternational Business MachinesLow International Business Machines (IBM) shares look more likely to lag the S&P 500 over three months because faster software growth leans on the Confluent deal while the 4%–5% 2026 revenue outlook stayed put. The full-year report expected…IBRXImmunityBioLow ImmunityBio's third-quarter Anktiva revenue of $48.7 million fell below the second quarter's $50.7 million, and the shares are more likely to lag the S&P 500 until detailed QUILT-2.005 efficacy data and a fourth-quarter revenue rebound…IBTAIbottaLow Ibotta's Q3 2026 beat is already in the price, and Koch's investment vehicle sold shares into the rally, so the stock is more likely to lag the S&P 500 over three months. The Q4 2026 report decides whether growth beats the $94–98 million…INTCIntelLow Intel's shares look more likely to lag the S&P 500 than lead it over the next three months, because the PC slump, Israel fab costs and cash burn are unresolved and Bank of America cut its target to $80 on 12 November 2026. Nvidia's 17…IONQLow IonQ's shares are more likely to lag the S&P 500 over three months as a sudden finance-chief exit and 34.6 million newly registered resale shares add to widening losses despite a raised $505–515 million 2026 revenue outlook. Gary Merrill's…IRENLow IREN Limited's shares look more likely to lag the S&P 500, because its AI cloud ramp is behind its own $4 billion operating revenue-rate target while Microsoft reassesses neocloud deals. Operating annual recurring revenue reported against…ISRGIntuitive SurgicalLow Intuitive Surgical's shares look more likely to lag the S&P 500 because US procedure growth slowed to 10% and instrument revenue per procedure is set to fall 3%–5% from 2027. The mid-January 2027 preliminary procedure count will show…JNJJohnson & JohnsonLow Johnson & Johnson's drug approvals keep coming, but weak medical devices and $1.36 per share of 2027 deal dilution leave the shares more likely to lag the S&P 500. The 8 December 2026 business review and January 2027 guidance settle it.JPMJPMorgan ChaseLow JPMorgan Chase's shares look more likely to trail the S&P 500 over three months after a third-quarter miss, a roughly 90% buyback cut and a reported Senate Epstein review; the 9 December 2026 CFO update and 14 January 2027 report decide it.KDKyndryl HoldingsLow Kyndryl's shares are more likely to lag the S&P 500 because profit and signings improved but free cash flow did not; the fiscal third-quarter report, around early February 2027, shows whether the $400–500 million cash target holds.KIDSOrthoPediatricsLow OrthoPediatrics shares are more likely to lag the S&P 500 because the $33.67 close on 11 November 2026 sits above six of seven post-report analyst targets despite 19% sales growth. Preliminary fourth-quarter revenue, expected about…KMPRKemperLow Kemper Corporation's third-quarter 2026 profit came with a personal auto book down about 10% in the quarter and an underlying combined ratio still above 100%. After a 30.7% three-month rise, the shares are more likely to lag the S&P 500…KOCoca-ColaLow Coca-Cola's shares are more likely to lag the S&P 500: at about 28 times forward earnings and above the average analyst target, the raised 2026 outlook looks priced in. The fourth-quarter report with first 2027 guidance, expected around 10…KODKodiak SciencesLow Kodiak Sciences' shares look more likely to lag the S&P 500 after a 161.8% three-month run that prices in the DAYBREAK win while share sales have begun. The PEAK topline, guided for December 2026, settles it.KSSKohlsLow Kohl's shares are more likely to lag the S&P 500, trading above the $17.25 consensus target on one upgrade and a refund-aided guidance raise; the Q3 report expected around 24 November 2026 shows whether $1.80–$2.40 EPS guidance holds.LACLithium AmericasLow Lithium Americas' shares are more likely to lag the S&P 500 because its 11 November 2026 Thacker Pass cost increase of $900 million to $3.83 billion adds to funding needs while dilution continues; year-end 2026 power energization and final…LIFEEthos TechnologiesLow Ethos Technologies' shares look more likely to lag the S&P 500: record third-quarter growth came from the short-seller-disputed agency channel while receivables and insider sales kept rising. The next customer-concentration disclosure and…LITELumentum HoldingsLow Lumentum Holdings' shares look more likely to lag the S&P 500 because a fixed 4.500-share Marvell merger ties them to Marvell's stock more than to Lumentum's growth. Marvell's 1 December 2026 quarterly report is the next test.LMNDLemonadeLow Lemonade's shares are more likely to lag the S&P 500 as a 65% loss ratio and a new S-3 registration offset its Q4 2026 profit target; the 17 November 2026 investor day and Q4 results settle it.LRCXLam ResearchLow Lam Research shares look more likely to lag the S&P 500 over the next three months because a buyback-led rebound still runs ahead of unresolved 2027 chip-equipment demand. Applied Materials' 12 November 2026 beat gave no 2027 figure; Lam's…METAMeta PlatformsLow Meta Platforms shares look more likely to lag the S&P 500 over three months: 26% ad growth faces $25 billion of forward-sale stock, new bonds and a roughly $60 billion Class C stock program that can start on 19 January 2027. Fourth-quarter…MODModine ManufacturingLow Modine Manufacturing's shares are more likely to lag the S&P 500 over three months: data-center sales rose 95% in the quarter to 30 September 2026, but their gross margin fell to 19.7%. The 18 November 2026 Investor Day, where management…MPMP MaterialsLow MP Materials shares look more likely to lag the S&P 500 over three months because General Motors magnet volumes start small and analysts keep cutting targets. The expected Trump–Xi meeting at APEC on 18 November 2026 and fourth-quarter…MRNAModernaLow Moderna's shares are more likely to lag the S&P 500 over three months: a 246.5% three-month gain already prices its surprise profit and melanoma vaccine, and 2027 guidance waits for the fourth-quarter report. The 18 November 2026 Jefferies…MRVLMarvell TechnologyLow Marvell Technology shares are more likely to lag the S&P 500 over the next three months because merger arbitrage gives its $115 billion all-stock Lumentum deal only even odds, leaving an overhang until 2028. The 1 December 2026 fiscal…MSTRStrategyLow Strategy Inc.'s common shares are more likely to lag the S&P 500: MSCI confirmed on 11 November 2026 that it will delete the stock at the 30 November close, and bitcoin trades below Strategy's $75,456 average cost. Weekly 8-K filings show…NBISNebius GroupLow Nebius Group's shares are more likely to lag the S&P 500 over three months because its 12 November 2026 report pushed Microsoft capacity into 2027 and raised 2026 spending to about $27 billion. The fourth-quarter report, expected around…NFLXNetflixLow Netflix's shares are more likely to lag the S&P 500 than lead it while members use the service less and its 2026 ad target sits cut; the fourth-quarter report and 2027 outlook, expected around 20 January 2027, decide whether engagement has…NIOLow NIO Inc. shares are more likely to lag the S&P 500 over three months because October deliveries fell 15.23% from a year earlier as ONVO collapsed. The third-quarter report, expected around 24 November 2026, and November deliveries in early…NKENikeLow Nike's shares are more likely to lag the S&P 500 over the next three months because revenue is still falling and analysts keep trimming targets; the 17 November 2026 Investor Day presentations and the December quarterly report show whether…NOWServiceNowLow ServiceNow's shares are more likely to lag the S&P 500 into the January 2027 report as slowing backlog growth and AI-competition fears outweigh a third-quarter beat. Fourth-quarter cRPO growth against the 18.5% guide decides the case.NRDSNerdWalletLow NerdWallet's shares are more likely to lag the S&P 500: its 5 November 2026 outlook guided fourth-quarter revenue down 13% with no fix date for auto insurance. The fourth-quarter report, estimated for late February 2027, shows whether 2027…NTRANateraLow Natera's shares are more likely to lag the S&P 500 into early 2027, because an abrupt CEO change on 5 November 2026 outweighed a revenue beat and raised guidance. The Q4 report, estimated for late February 2027, tests Signatera growth…NUNu HoldingsLow Nu Holdings shares are more likely to lag the S&P 500 over the next three months, as rising 90-day delinquencies and a post-election Brazil discount outweigh record profit. The 8 December 2026 Investor Day is the next test of that view.NVDANVIDIALow NVIDIA's shares are more likely to lag the S&P 500 over the next three months because Jensen Huang's 12 November 2026 resignation left an interim CEO, an open board investigation and seven broker downgrades. The 17 November 2026 quarterly…OKLOLow Oklo Inc. shares lean toward lagging the S&P 500 because its first Aurora plant still has no published cost and the company keeps selling stock. A disclosed plant cost and a quarter of slower share issuance would show that view wrong.ONDSOndasLow Ondas Inc. shares are more likely to lag the S&P 500 over three months: the 12 November 2026 report beat on revenue but halved margins and widened losses, and the fourth-quarter 2026 report, expected around March 2027, settles whether…OPCHOption Care HealthLow Option Care Health's $32.05-per-share cash sale to CD&R and McKesson caps the shares, which closed at $31.70 on 11 November 2026, so they are more likely to lag than lead the S&P 500. The 3 December 2026 antitrust waiting-period expiry and…ORCLOracleLow Oracle's shares look more likely to lag the S&P 500 over the next three months, as Microsoft's exit from rented capacity, a scrapped Tencent lease and heavy cash burn outweigh a peer-led rebound. The fiscal second-quarter 2027 report,…OSPNOneSpanLow OneSpan's move from hardware tokens to subscription software is working, but its guidance implies a slower fourth quarter after a 32.1% three-month rise, so the shares are more likely to lag the S&P 500. The report expected in late…OSWOneSpaWorld HoldingsLow OneSpaWorld, the spa operator on most large cruise ships, raised 2026 guidance but its shares already trade near analysts' targets and are more likely to lag the S&P 500; Carnival's December outlook and the late-February report decide it.PANWPalo Alto NetworksLow Palo Alto Networks shares are more likely to lag the S&P 500 until AI security demand lifts its $14.10B–$14.20B fiscal 2027 revenue outlook; the 18 November 2026 fiscal Q1 report settles it. Jefferies cut its target to $400 from $450 on 12…PCRXPacira BioSciencesLow Pacira BioSciences trades as a pending takeover pinned near Viatris's $36.50 cash offer, so the shares are more likely to lag the S&P 500 than lead it. The tender offer expiring on 16 November 2026, with antitrust clearance already…PDPagerDutyLow PagerDuty's shares are more likely to lag the S&P 500 over three months because a 32.1% three-month rally has run ahead of revenue growth of 0.8%. Fiscal third-quarter results, expected around 24 November 2026, test whether revenue and 98%…PEPPepsiCoLow PepsiCo shares look more likely to lag the S&P 500 over three months because North American snack profit and drink volume are shrinking while the stock has already climbed back to its 200-day average. The fourth-quarter report and first…PLTRPalantir TechnologiesLow Palantir Technologies looks more likely to lag the S&P 500 over three months because contract signings grew only 6% in the third quarter while revenue grew 96%; the fourth-quarter report, expected around 1 February 2027, shows whether…PLUGPlug PowerLow Plug Power's record-low $28 million Q3 2026 cash usage is real progress, but gross margin of about −3% was worse than Q2's −0.9%; Q4 targets of positive adjusted earnings and flat cash usage settle the next read.POOLLow Pool Corporation's shares closed at $221.05 on 9 November 2026, above the average analyst target after a third quarter of flat EPS, so they look more likely to lag the S&P 500 than lead it. The February 2027 report and its 2027 outlook…PSNLPersonalisLow Personalis trades as a fixed $16.25-per-share claim on Tempus AI's agreed takeover, so the shares are more likely to lag the S&P 500 than lead it; the 30 November 2026 stockholder vote and the closing settle it.PTCLow PTC Inc. is pinned just below Schneider Electric's $205-per-share cash offer, which the buyer called best and final, so the shares are more likely to lag the S&P 500 than lead it. Antitrust and CFIUS reviews, the shareholder vote and a…PZZAPapa John's InternationalLow Papa John's shares are more likely to lag the S&P 500 over the next three months: North America comparable sales fell 8.3% in the third quarter of 2026 and the 2026 outlook was cut again. The fourth-quarter report in late February 2027…QBTSD-Wave QuantumLow D-Wave Quantum's shares are more likely to lag the S&P 500 over three months because third-quarter orders fell to $1.9 million and five brokers cut targets on 11 November 2026. The fourth-quarter report, expected around 26 February 2027,…QCOMQUALCOMMLow Qualcomm's shares are more likely to lag the S&P 500 over three months: handset revenue fell 26% and the December-quarter chip margin is guided to 20% to 22% while data-center revenue is still small. The early-February 2027 report shows…QDELQuidelOrthoLow QuidelOrtho's shares are more likely to lag the S&P 500: third-quarter revenue fell 11.6% and net leverage rose to 4.5 times while the point-of-care sale meant to cut $2.94B of borrowings is still unsigned. A signed deal or the…RDDTRedditLow Reddit, Inc. shares are more likely to lag the S&P 500: falling search traffic threatens its daily user count despite 53% revenue growth. The February 2027 fourth-quarter report settles it.RGTIRigetti ComputingLow Rigetti Computing's shares look more likely to lag the S&P 500 after third-quarter 2026 revenue of $1.41 million missed a $3.52 million consensus; India's C-DAC accepting its 108-qubit system by 31 December 2026 decides whether the roughly…RIGTransoceanLow Transocean's shares are more likely to lag the S&P 500: its roughly $8 billion offshore-rig backlog has not lifted earnings, and 2027 revenue is guided flat at $3.85–4.0 billion. The 24 November 2026 Valaris votes and the deal's targeted 1…RNGRingCentralLow RingCentral's shares look more likely to lag the S&P 500 than lead it because software-sector selling has outweighed a third-quarter beat. The fourth-quarter report expected around 19 February 2027 settles whether revenue growth moves past…RPDRapid7Low Rapid7's shares look more likely to lag the S&P 500: cost cuts drove a third-quarter profit beat on 4 November 2026, but the company guides recurring revenue lower again for the fourth quarter. The February 2027 report and first 2027…RRCRange ResourcesLow Range Resources is likely to lag the S&P 500 because its shares now trade as 0.987 EQT shares under EQT's all-stock takeover, with the premium priced in; EQT's share price, gas prices and the shareholder votes before a first-quarter 2027…RXOLow RXO, Inc. is likely to lag the S&P 500 because C.H. Robinson's pending $17.25-cash-plus-0.0856-share takeover caps its upside. Antitrust review, the registration statement and the shareholder vote settle the deal, with closing targeted for…RYZRyerson HoldingLow Ryerson Holding's shares are more likely to lag the S&P 500 over three months despite an Olympic Steel merger running ahead of plan, because the 5 November 2026 fall is unexplained and fourth-quarter earnings are guided lower. The report…SEPNSepternaLow Septerna's shares are more likely to lag the S&P 500 over the next three months after a third-quarter 2026 revenue and loss miss on 9 November 2026; SEP-479 Phase 1 liver-safety data, due in the first quarter of 2027, settle the case.SGRYSurgery PartnersLow Surgery Partners' shares, at $26.58 on 12 November 2026, already price in more than HealthSpan Partners' $25.00 cash deal pays and are more likely to lag the S&P 500. Whether the rejected $28.00 bidder, reported to be UnitedHealth, returns…SLNSilence TherapeuticsLow Silence Therapeutics' shares trade just under Merck KGaA's $20-per-ADS cash takeover price, so they are more likely to lag the S&P 500 than lead it over three months. The proxy statement that dates the scheme vote, and antitrust clearance…SLSSELLAS Life Sciences GroupLow SELLAS Life Sciences is more likely to lag the S&P 500 over three months: its value rests on one Phase 3 leukemia trial, REGAL, whose topline survival result the company said on 12 November 2026 it expects this month, and the shares closed…SMCISuper Micro ComputerLow Super Micro Computer's shares are more likely to lag the S&P 500 as record sales come with a 12.7% gross margin, a 44% customer and a new China export-control report. The December-quarter result, guided at $19.5–21.5 billion, settles it.SMRNuScale PowerLow NuScale Power's shares are more likely to lag the S&P 500 because the binding ENTRA1–TVA power purchase agreement its case needs is still unsigned and undated. A signed agreement, or none by year-end 2026, settles the case.SNDKSandiskLow Sandisk's shares look more likely to lag the S&P 500 as investors price a peak in NAND flash prices after October contract prices went flat. TrendForce's November prices, Micron's December report and Sandisk's late-January results will…SNOWSnowflakeLow Snowflake's shares look more likely to lag the S&P 500, trading on AI sentiment at 19 times sales despite 37% product revenue growth; the 2 December 2026 Q3 report tests the $1,588 million guidance floor.SNXTD SYNNEXLow TD SYNNEX's Hyve server growth is consuming cash and the company just added a $1.75 billion term loan, so the shares are more likely to lag the S&P 500. The January fiscal Q4 report settles it by showing whether operating cash flow turns…SOFISoFi TechnologiesLow SoFi Technologies' shares are more likely to lag the S&P 500 after a hot October inflation report made a December Fed hike near-certain, despite a 2027 outlook above consensus. The 9 December 2026 Fed decision and the fourth-quarter report…SOUNSoundHound AILow SoundHound AI's shares are more likely to lag the S&P 500 over three months: gross margin fell and cash burn continues while breakeven is set for late 2027; the fourth-quarter report, expected around late February 2027, first tests the…SPCXSpaceXLow SpaceX shares are more likely to lag the S&P 500 because Anthropic, its largest compute customer, can leave its contracts in early 2027. The 1 December 2026 billing start of a $1.11-billion-a-month hosting deal is the first test of whether…SWIMLatham GroupLow Latham Group's fiberglass share gains lift sales 12.5%, but its shares, up 11.9% in three months, look likely to lag the S&P 500 as management plans for a flat 2027 pool market. The 2027 outlook in early March 2027 settles it.TET1 EnergyLow T1 Energy's shares are more likely to lag the S&P 500 over three months because its G2_Austin cell plant still lacks closed financing and unrestricted cash was $59.5 million at 30 September 2026; a financing close, targeted by year-end…TEMTempus AILow Tempus AI shares are more likely to lag the S&P 500 over the next three months: third-quarter revenue of $411.5 million matched forecasts and the 2026 guide rose only at its low end, after a 46.3% three-month gain. The Personalis vote on…TENTsakos Energy NavigationLow Tsakos Energy Navigation's shares look more likely to lag than lead the S&P 500 because about 80% of its fleet is on fixed charters that pass only part of record tanker rates into earnings. Its 19 November 2026 third-quarter report shows…TENBTenable HoldingsLow Tenable's revenue growth is guided to slow to about 6.9% in the fourth quarter from 9.5%, so its shares are more likely to trail the S&P 500 than lead it; the February 2027 report and first 2027 outlook show whether the Tenable One…TRUPTrupanionLow Trupanion's third-quarter beat is already in its share price, so the pet insurer's stock looks more likely to lag the S&P 500: the post-report gain faded by 10 November 2026 and new Stifel and Cantor targets sit at or below the price. The…TSLATeslaLow Tesla's shares look more likely to lag the S&P 500 over three months: operating income fell 56% while the price ran up on unsigned SpaceX merger talks. Terms, which Bloomberg says could come as soon as December, and the early-January…TWSTTwist BioscienceLow Twist Bioscience shares are more likely to lag the S&P 500 because its fiscal 2027 outlook assumes AI drug-discovery revenue grows far slower than the 175% of fiscal 2026. The fiscal first-quarter report expected in early February 2027…TXG10x GenomicsLow 10x Genomics' shares are more likely to lag the S&P 500 over the next three months: third-quarter revenue grew 1% and analysts cut targets after the report. The fourth-quarter Atera count against a plan of about 50 units settles it.ULCCFrontier Group HoldingsLow Frontier Group Holdings (Frontier Airlines) shares are more likely to lag the S&P 500: a $7.70 close on 12 November 2026 sits above most post-report targets as officers sold stock. The early-2027 fourth-quarter report settles whether…UPSTUpstart HoldingsLow Upstart Holdings is more likely to lag the S&P 500 over the next three months: it cut its 2026 outlook and October lending slowed. November originations and the fourth-quarter report will show whether the slowdown deepens or reverses.USARUSA Rare EarthLow USA Rare Earth shares look more likely to lag the S&P 500 over three months because third-quarter revenue fell to $3.0 million and the gross loss widened to $19.9 million. The company's goal of magnet sales to multiple customers by the end…VVisaLow Visa's shares are more likely to trail the S&P 500 than lead it over three months: at about 34 times trailing earnings the price reflects the franchise, while Visa's fiscal 2027 outlook slows earnings growth in a heavy contract-renewal…VALValarisLow Valaris shares are more likely to lag the S&P 500 because they trade as Transocean stock at 15.235 shares each, and Transocean's 2 November 2026 results showed lower revenue and a flat 2027 outlook. The 24 November 2026 votes, the 26…VFCV.F.Low V.F. Corporation's shares look likely to lag the S&P 500 because they already price in a Vans recovery that results have not shown. The third-quarter report, estimated for about 27 January 2027, settles whether Vans improves to a…VKTXViking TherapeuticsLow Viking Therapeutics is more likely to lag the S&P 500 over three months: $960 million in cash funds its obesity Phase 3 trials, but no pivotal efficacy result is scheduled before 2027. The ObesityWeek posters from 15 November 2026 add…VSXYVictoria's SecretLow Victoria's Secret & Co.'s shares are more likely to lag the S&P 500 after running past most analyst targets, with BofA cutting them to Neutral on 12 November 2026. The 3 December 2026 third-quarter report shows whether sales clear the top…WFCWells FargoLow Wells Fargo's shares are more likely to lag the S&P 500 than lead it because third-quarter fees fell and credit costs rose while guidance was only held. The 14 January 2027 fourth-quarter report settles it by showing whether net interest…WINGWingstopLow Wingstop's shares have run ahead of its business and are more likely to lag the S&P 500: they rose 46.8% in three months to $166.73 on 11 November 2026 despite a third cut to same-store-sales guidance. The fourth-quarter report, expected…WMTWalmartLow Walmart shares look more likely to trail the S&P 500 over the next three months because brokers already priced in its advertising- and membership-driven profit growth. The 19 November 2026 third-quarter report shows whether results can…XEX-EnergyLow X-Energy's shares are more likely to lag the S&P 500 over three months: the NRC approved Dow's Long Mott permit on 9 November 2026, but the 12 November 2026 report showed losses widening and first power stays in the early 2030s. Dow's 2027…XOMExxon MobilLow Exxon Mobil's shares are more likely to lag the S&P 500 as Brent's war premium unwinds and Goldman Sachs and Bernstein cut targets. The January 2027 fourth-quarter report settles it by showing whether refining profit held near $9.1 billion.YEXTLow Yext's margin recovery needs its AI products to restart recurring-revenue growth; the Q3 fiscal 2027 report, expected in early December 2026, must show total annual recurring revenue above the $440.8 million reported on 1 September 2026.ZMZoom CommunicationsLow Zoom Communications shares are more likely to lag the S&P 500 than lead: enterprise growth is improving but total revenue grows near 5%, and the 23 November 2026 third-quarter report must deliver a bigger raise than the market expects.AAOIApplied OptoelectronicsLow Applied Optoelectronics is more likely to lag the S&P 500 over three months: its $385–420 million fourth-quarter revenue guide trails consensus and a DSP chip shortage limits 1.6-terabit shipments. Nvidia's 17 November 2026 report tests AI…ABEOAbeona TherapeuticsLow Abeona Therapeutics' ZEVASKYN revenue grew 18% to $13.5 million in the third quarter but missed estimates, and a $3.75-a-share placement plus a stock-funded drug purchase left the shares at $2.30; they are more likely to lag the S&P 500.ABSIAbsciLow Absci Corporation's shares are more likely to lag the S&P 500 over three months because the price still assumes a hair-loss win for ABS-201; the 13-week interim data guided for December 2026 settle it.ABTAbbott LaboratoriesLow Abbott Laboratories' shares are more likely to lag the S&P 500 over three months: the 2026 comparable growth guide was cut to about 6.0% on 21 October 2026, and the late-January 2027 fourth-quarter report and 2027 guidance decide whether…ACDCProFrac HoldingLow ProFrac Holding's shares are more likely to lag the S&P 500 over three months: third-quarter Stimulation Services margin stayed at 9%, flat on the second quarter, and the shares closed at $3.19 on 12 November 2026. The fourth-quarter…ACHRArcher AviationLow Archer Aviation's pending Boeing-unit purchase would add Insitu's stated $200 million-plus of annual revenue to an air-taxi developer reporting $5.1 million a quarter, but a wider loss guide leaves the shares more likely to lag the S&P…ACMRACM ResearchLow ACM Research's third-quarter gross margin of 41.6% fell under its 42% floor despite revenue up 36.6% and a raised 2026 outlook, so the shares are more likely to lag the S&P 500 over three months; fourth-quarter results in 2027 settle it.ADSKAutodeskLow Autodesk's shares are more likely to lag the S&P 500 over three months: the rebound on Schneider Electric's PTC takeover has no new company result behind it, and the 24 November 2026 fiscal third-quarter report settles whether contracted…ADTNADTRAN HoldingsLow ADTRAN Holdings' shares are more likely to lag the S&P 500 over three months: fourth-quarter revenue is guided flat, operating cash flow turned negative and the company can issue stock. The fourth-quarter report, expected around February…AEHRAehr Test SystemsLow Aehr Test Systems reported record quarterly revenue of $33.0 million and lifted fiscal 2027 guidance to $150 million, yet the shares closed at $65.78 on 11 November 2026, under both moving averages, and are more likely to lag the S&P 500…AEMAgnico Eagle MinesLow Agnico Eagle Mines is more likely to lag the S&P 500 over three months: third-quarter unit costs rose about 24% and the shares closed at $185.96 on 11 November 2026. The fourth-quarter report, expected around February 2027, settles whether…AEOAmerican Eagle OutfittersLow American Eagle Outfitters' shares are more likely to lag the S&P 500 over three months: Aerie grows, but the namesake brand shrinks and tariff refunds inflate profit. The ~2 December 2026 third-quarter report settles it.AESIAtlas Energy SolutionsLow Atlas Energy Solutions, a Permian sand producer turning into a power developer, is more likely to lag the S&P 500 over three months: it closed at $5.50 on 12 November 2026 with its data center power contracts unsigned. Management's…AEYEAudioEyeLow AudioEye's shares are more likely to lag the S&P 500: the company is profitable, but sales grew 7%, the executive chairman kept selling, and the stock is up 137% in three months; the Q4 report decides it.AGCOLow AGCO Corporation's farm-equipment recovery now rests on 2027 after a third-quarter sales miss and a 2026 sales guidance cut on 29 October 2026, so the shares are more likely to lag the S&P 500; Deere's expected 25 November 2026 report is…AGENAgenusLow Agenus is more likely to lag the S&P 500 over three months: the shares closed at $6.87 on 12 November 2026, and its funded ROBBIN colon cancer Phase 3 has no pivotal milestone before first-patient dosing guided for the first quarter of…AGIOAgios PharmaceuticalsLow Agios Pharmaceuticals' shares are more likely to lag the S&P 500 until the FDA rules on mitapivat in sickle cell disease by 1 February 2027; thalassemia sales are growing, but new prescriptions are slowing and a safety program is possible.AGLTChurchill Capital Corp XILow Agility Robotics (AGLT), the humanoid-robot maker listed via its 4 November 2026 merger with Churchill Capital Corp XI, is more likely to lag the S&P 500: revenue is small, and resale of about two-thirds of shares is registered.AGMFederal Agricultural MortgageLow Federal Agricultural Mortgage Corporation (Farmer Mac) is more likely to lag the S&P 500 over three months: record loan volume has not lifted earnings, and core earnings per share of $4.82 missed the $5.20 estimate. The fourth-quarter 2026…AGXArganLow Argan's order book shrank to $2.518 billion in its latest quarter, so the shares are more likely to lag the S&P 500 over three months; the third-quarter fiscal 2027 report, expected around 4 December 2026, shows whether new awards are…AIFFFirefly NeuroscienceLow Firefly Neuroscience's third-quarter revenue rose to $647,000, but cash fell to $8.0 million with going-concern doubt unresolved, and the shares at $0.96 are more likely to lag the S&P 500; unannounced revenue terms from its partnerships…AIROAIRO Group HoldingsLow AIRO Group Holdings is more likely to lag the S&P 500: it beat third-quarter 2026 revenue estimates and lifted backlog to about $200 million, but moved full-year growth to the low end and cash fell to $37.8 million. The fourth-quarter…AKAMAkamai TechnologiesLow Akamai Technologies' AI cloud pivot has a 2027 outlook behind it, but the shares are more likely to lag the S&P 500 over three months: margins fell, debt is rising and Evercore ISI downgraded them. The fourth-quarter report, expected…AKBAAkebia TherapeuticsLow Akebia Therapeutics is more likely to lag the S&P 500 over three months: third-quarter 2026 revenue of $36.9 million missed estimates and Vafseo's price resets when the add-on payment ends on 31 December 2026, alongside a pending term loan…AKTSAktis OncologyLow Aktis Oncology's shares are more likely to lag the S&P 500 over three months: its lead radiopharmaceutical AKY-1189 has no efficacy data, and preliminary NECTINIUM-2 results, guided for the first quarter of 2027, settle the case.ALGMAllegro MicroSystemsLow Allegro MicroSystems is more likely to lag the S&P 500 over three months: the shares closed at $31.71 on 12 November 2026, down 28.6% in three months despite a fiscal second-quarter beat. Fiscal third-quarter results around 29 January 2027…ALHCAlignment HealthcareLow Alignment Healthcare's 29 October 2026 cut to full-year profit guidance makes the shares more likely to lag the S&P 500 over three months; the fourth-quarter report, expected around February 2027, shows whether medical costs are turning.ALKAlaska Air GroupLow Alaska Air Group's shares are more likely to lag the S&P 500 over three months: a jet fuel bill has erased 2026 earnings, and the fourth-quarter report, guided at a $2.00 to $2.50 adjusted loss per share, settles whether 2027 repair is…ALMSAlumisLow Alumis, a one-drug psoriasis company, is more likely to lag the S&P 500 over three months: cash fell to $431.3 million and lupus has no funded path. The envudeucitinib NDA filing guided for the quarter ending 31 December 2026 settles it.ALTOAlto IngredientsLow Alto Ingredients beat third-quarter 2026 profit estimates, but Pekin Campus production gross profit fell to $9.5 million from $18.9 million while clean-fuel credits filled the gap. The shares are more likely to lag the S&P 500 until core…ALVOAlvotechLow Alvotech's shares are more likely to lag the S&P 500 because cash fell to $61.5 million at 30 September 2026 and 2026 revenue is now guided to the low end. FDA decisions on its Simponi and Eylea biosimilars, AVT05 and AVT06, expected in Q4…AMBAAmbarellaLow Ambarella's shares are more likely to lag the S&P 500 over three months: they sit below their 50-day and 200-day averages and the reported NXP sale talks have not lifted them; the third-quarter fiscal 2027 report on 24 November 2026…AMKRAmkor TechnologyLow Amkor Technology is more likely to lag the S&P 500 over three months: third-quarter gross margin of 18.3% missed the guided 18.5–19.5%, and the shares trade below both major averages. The fourth-quarter report, expected around February…AMLXAmylyx PharmaceuticalsLow Amylyx Pharmaceuticals' shares are more likely to lag the S&P 500 because avexitide's Phase 3 win and $768.1 million of cash are already public, and the stock sits below the $35.50 August offering price. The 15 November 2026 full LUCIDITY…AMRAlpha Metallurgical ResourcesLow Alpha Metallurgical Resources is more likely to lag the S&P 500: 2027 cost guidance of $104–$110 per ton sits above 2026's $103–$107 while committed 2027 prices are lower. The fourth-quarter report settles it.AMSCAmerican SuperconductorLow American Superconductor's grid-equipment orders and profit are slowing from a strong September quarter, so the shares are more likely to lag the S&P 500 over three months; the February 2027 report settles it.ANABAnaptysBioLow AnaptysBio's shares are more likely to lag the S&P 500 over three months because their value rests on an undated Delaware Chancery judgment on returning Jemperli rights from GSK's Tesaro unit, expected in the fourth quarter of 2026 or the…ANFAbercrombie & FitchLow Abercrombie & Fitch's margin reset (19.9% operating margin in Q2 fiscal 2026) holds the case together, but the shares have slipped 10.0% from a $171.09 high to a $154.00 close; the confirmed 24 November 2026 Q3 report settles whether…ANROAlto NeuroscienceLow Alto Neuroscience's depression program is funded through 2030 on company guidance, and the 10 November 2026 report left every timeline intact, but the shares have rallied hard with no efficacy data until 1H 2027 and are more likely to lag…APHAmphenolLow Amphenol's record orders have not stopped the AI-hardware de-rating, and its shares look more likely to lag the S&P 500; Nvidia's 17 November 2026 results and Amphenol's late-January 2027 report decide whether data-center demand restores…APLDApplied DigitalLow Applied Digital's data-centre rent is growing, but financing for about 800 MW of unbuilt capacity at rising costs makes the shares more likely to lag the S&P 500 over three months; financing terms and fiscal Q2 2027 rental revenue settle…APPSDigital TurbineLow Digital Turbine shares are more likely to lag the S&P 500: its 9 November 2026 report raised sales guidance but held profit guidance, showed gross margin down to 43% and disclosed a material weakness in controls. The fiscal third-quarter…AQSTAquestive TherapeuticsLow Aquestive Therapeutics' shares lean toward lagging the S&P 500 over three months: the FDA decision on its needle-free epinephrine film Anaphylm falls on 16 March 2027, after the window, and third-quarter revenue of $7.6 million missed…ARCTArcturus Therapeutics HoldingsLow Arcturus Therapeutics has cash into 2028 but no dated FDA path for ARCT-810 and no dated Phase 3 decision for ARCT-032, so the shares are more likely to lag the S&P 500 until the company sets those dates.ARECAmerican ResourcesLow American Resources Corporation, a former coal producer pivoting to critical minerals, is more likely to lag the S&P 500: two quarterly reports are overdue and the 16 November 2026 Nasdaq filing deadline settles the case.ARESAres ManagementLow Ares Management's fee earnings still rise, but the 29 October 2026 report slowed fee growth and trimmed three 2026 targets, so the shares are more likely to lag the S&P 500 until fourth-quarter fundraising and deployment arrive.ARISAris MiningLow Aris Mining Corporation's shares are more likely to lag the S&P 500: Q3 missed estimates on higher costs and 2026 output is aimed at the low end of guidance. The Marmato first gold pour, targeted for December 2026, settles it.ARQQArqit QuantumLow Arqit Quantum is more likely to lag the S&P 500 over three months: preliminary fiscal 2026 revenue of about $1 million missed the $1.2 million expected after a Middle East contract stopped. December 2026 full results show whether NATO work…ARTVArtiva BiotherapeuticsLow Artiva Biotherapeutics is more likely to lag the S&P 500 over three months: its $319.1 million of cash depends on a board strategic review with no set date, and the shares have no scheduled event to settle it.ARXAccelerant HoldingsLow Accelerant Holdings is more likely to lag the S&P 500 over three months: Thoma Bravo's $20.25 per share cash offer caps the upside from the $19.89 close on 12 November 2026. Regulatory approvals and the shareholder vote settle whether the…ASANAsanaLow Asana's shares are more likely to lag the S&P 500 because guided growth slows to 8–9% and net revenue retention is 97%. The 1 December 2026 fiscal third-quarter report settles whether AI products reverse that.ASMBAssembly BiosciencesLow Assembly Biosciences is more likely to lag the S&P 500 over three months: the shares closed at $20.18 on 12 November 2026, down 38.8% in three months, and Gilead's GS-1179 Phase 2 start, due by 31 December 2026, settles whether the case…ASOAcademy Sports and OutdoorsLow Academy Sports and Outdoors shares, up 42.1% in three months to $69.32, are more likely to lag the S&P 500 while comparable sales are negative and EPS guidance leans on one-time tariff refunds; the ~8 December 2026 report settles it.ASPNAspen AerogelsLow Aspen Aerogels is more likely to lag the S&P 500: fourth-quarter revenue is guided below the third quarter and a $150 million registration allows new shares, despite a rebound to $6.41. The fourth-quarter report settles it.ASSTStriveLow Strive, Inc. funded about 43,000 bitcoin with 13% to 15% preferred stock, but weekly buying fell to 124 and 29 bitcoin after 30 October; the 16 November filing and the SATA December dividend rate show whether funding still works.ASTHAstrana HealthLow Astrana Health is more likely to lag the S&P 500 over three months: fourth-quarter adjusted EBITDA is guided to $48.5–61.5 million against $77.2 million in the third quarter, and Medicaid costs run above plan. Medicare Advantage contracts…ASXASE Technology HoldingLow ASE Technology's October sales kept it on track for fourth-quarter guidance, but heavy capital spending and a volatile chip sector leave the shares more likely to lag the S&P 500. The November sales release around 10 December 2026 and the…ASYSAmtech SystemsLow Amtech Systems' June-quarter AI-packaging orders and margins improved, but the shares are more likely to lag the S&P 500 until the report expected around 9 December 2026 shows the $28.7 million backlog turning into revenue growth.ATEXAnterixLow Anterix's 900 MHz spectrum case still lacks a signed deal: its 10 November 2026 quarterly report showed no new utility agreement, no buyback and no strategic-review timetable, so the shares are more likely to lag the S&P 500 until a…AUAngloGold AshantiLow AngloGold Ashanti's third-quarter report missed on volume and cost: output fell to 696,000 ounces and all-in sustaining cost rose to $2,170 an ounce, though full-year guidance held. The fourth-quarter output decides whether the guidance is…AUGOAura MineralsLow Aura Minerals' record third quarter did not bring costs inside full-year guidance, so the shares are more likely to lag the S&P 500 than lead it; fourth-quarter all-in sustaining cost, due with results around 24 February 2027, settles it.AURAurora InnovationLow Aurora Innovation's driverless-truck case rests on a schedule reset: guidance was cut on 28 October 2026 and four brokers lowered targets after. Production of about 20 trucks a week by early December settles whether the 200-truck goal…AUTLAutolus TherapeuticsLow Autolus Therapeutics' shares are more likely to lag the S&P 500 because AUCATZYL sales fell to $41.2 million in the third quarter and the shares closed at $1.24 on 11 November 2026 despite a raised outlook; fourth-quarter sales decide…AVLNAvalyn PharmaLow Avalyn Pharma's shares are more likely to lag the S&P 500 over three months: the inhaled-antifibrotic case has no efficacy data until the MIST Phase 2b readout in the second half of 2027, and the 18 November 2026 conference update is the…AVRAnteris Technologies GlobalLow Anteris Technologies is more likely to lag the S&P 500 over three months: its DurAVR heart-valve trial is funded, but spending is rising and a $250 million stock-sale program is open; the December-quarter cash report in late January 2027…AVTXAvalo TherapeuticsLow Avalo Therapeutics' abdakibart keeps a funded Phase 3 plan in hidradenitis suppurativa, but the shares sit near $7 after AbbVie's rival data; FDA feedback on the Phase 3 design, guided for H2 2026, settles the case.AVXLAnavex Life SciencesLow Anavex Life Sciences is more likely to lag the S&P 500: the shares hit a 52-week closing low of $1.06 on 11 November 2026 after three directors quit. The FDA's Rett pediatric meeting and the fiscal year-end report settle whether the slide…AYAAya Gold & SilverLow Aya Gold & Silver's third-quarter operating cash flow of US$48 million matched Q2 despite 21% more output, so the shares are more likely to lag the S&P 500; Q4 cash flow settles whether volume converts into cash.AZZLow AZZ Inc.'s galvanizing recovery is real, but the shares sit under their 50- and 200-day averages and are more likely to lag the S&P 500; the fiscal third-quarter report, expected around 7 January 2027, decides whether the raised guidance…BAKBraskemLow Braskem's creditor talks have no agreement and shareholders withdrew their funding offer on 6 November 2026, so heavy dilution for the listed ADR is likelier than a clean deal; the creditor-support deadline of about 22 November 2026…BANDBandwidthLow Bandwidth's shares, at $46.29 on 12 November 2026 after a rebound from $37.80, look more likely to lag the S&P 500 over three months; fourth-quarter results, expected in February 2027 against a $242–247 million revenue guide, settle it.BAXBaxter InternationalLow Baxter International's shares are more likely to lag the S&P 500: sales growth recovered to 5%, but third-quarter margins fell and 2027 carries cost headwinds. The February 2027 guidance settles whether earnings follow sales.BBBlackBerryLow BlackBerry's QNX automotive-software unit has a royalty backlog above $1.2 billion and a new Valeo camera partnership, but the shares sit near most analyst targets; the planned 17 December 2026 quarterly report decides whether revenue…BBARBanco BBVA ArgentinaLow Banco BBVA Argentina's US-listed shares are more likely to lag the S&P 500 because they trade on Argentine sovereign risk, which hit 831 basis points on 3 November 2026; the third-quarter report on 24 November 2026 shows whether credit…BBNXBeta BionicsLow Beta Bionics' shares are more likely to lag the S&P 500 while iLet buyers wait for the Mint patch pump's Q1 2027 launch; Mint shipments and coverage at the early-2027 report settle it.BBYBest BuyLow Best Buy shares are more likely to lag the S&P 500 after a 24.5% three-month rise put them above recent analyst targets while Q3 guidance implies slower growth. The 24 November 2026 Q3 fiscal 2027 report settles it.BCAXBicara TherapeuticsLow Bicara Therapeutics' shares are more likely to lag the S&P 500 because Genmab's rival head-and-neck drug won a Phase 3 trial and Bicara's own randomized data arrive only in mid-2027. Full FORTIFI-HN01 enrollment and $442.3 million of cash,…BHBiglari HoldingsLow Biglari Holdings' Class B shares are more likely to lag the S&P 500: third-quarter Steak n Shake earnings improved, but nine-month operating earnings are lower and stock issuance continues. The fourth-quarter report settles it.BHEBenchmark ElectronicsLow Benchmark Electronics' shares are more likely to lag the S&P 500 over three months: they closed at $64.81 on 12 November 2026, down 20.6% in three months, despite a 28 October 2026 beat and raised outlook; the early-2027 fourth-quarter…BIOABioAge LabsLow BioAge Labs' shares are more likely to lag the S&P 500 than lead it until the QUELL-CV hsCRP topline for BGE-102, guided to the fourth quarter of 2026, shows whether Phase 1 biomarker results hold against placebo.BIRDSmartbirdLow Smartbird, the former Allbirds, is more likely to trail the S&P 500: its AI-cluster rental business has added supplier and data center deals but names no paying customer. The third-quarter 10-Q, due around 16 November 2026, shows whether…BIRKBirkenstock HoldingLow Birkenstock Holding plc's shares are more likely to lag the S&P 500 than lead it: they closed at $36.61 on 11 November 2026, below the 200-day average, with the Americas wholesale debate unresolved until the 10 December 2026 full-year…BKNGBooking HoldingsLow Booking Holdings is more likely to lag the S&P 500 over three months because it guided fourth-quarter room-night growth down to 1%–3% with flat adjusted EBITDA. The fourth-quarter report, expected in late February 2027, shows whether…BLDPBallard Power SystemsLow Ballard Power Systems has not been rewarded for the GeoPura deal or its new margin targets; the shares closed at $1.48 on 10 November 2026, and the 16 November 2026 Q3 report decides whether revenue and backlog confirm the case.BLKBBlackbaudLow Blackbaud's shares are more likely to lag the S&P 500 over three months: the 28 October 2026 report held the upper-half 2026 guide, but a renewal cohort 40% larger will slow contract growth into 2027. The fourth-quarter report, estimated…BLMNBloomin' BrandsLow Bloomin' Brands raised its FY2026 adjusted EPS range to $0.97–$1.02 on 6 November 2026, but traffic fell 1.8% and its Q4 guide trails estimates; the late-February 2027 report decides whether margin repair holds.BLSHBullishLow Bullish's shares are more likely to lag the S&P 500 over the next three months: October trading volume fell to $37.7 billion and no issuer has committed to tokenization. The 18 November 2026 third-quarter report settles whether revenue…BMABanco MacroLow Banco Macro's shares are more likely to lag the S&P 500: they closed at a 52-week closing low of $57.23 on 11 November 2026 despite a buyback. The third-quarter results, not yet confirmed for a date, settle whether bad loans are rising.BMEABiomea FusionLow Biomea Fusion is more likely to lag the S&P 500 over three months: cash fell to $26.8 million at 30 September 2026 and BMF-650 has no partner; the 16 November 2026 ObesityWeek poster and any financing news settle it.BMNRBitMine Immersion TechnologiesLow BitMine Immersion, the largest corporate ether holder, is likely to lag the S&P 500: it held 4.97% of ether supply against a stated 5% cap and booked a $6.3 billion fiscal 2026 loss. The weekly holdings releases through late November show…BOLDBoundless BioLow Boundless Bio is more likely to lag the S&P 500 over three months: the Serapha Bio deal offers a $44–48 million cash dividend plus about 3.8% of the combined company. The 3 December 2026 shareholder vote and a per-share declaration settle…BOOMDMC GlobalLow DMC Global's shares look more likely to lag the S&P 500 than lead it: the fourth-quarter guide steps down and the $187.1 million Arcadia minority put is still open, despite a real cost-cut recovery. The fourth-quarter report, expected…BOXLow Box's AI-driven growth is improving, but at $43.55 the shares already sit above the $39.80 average analyst target and look more likely to lag the S&P 500. Box's 1 December 2026 third-quarter report settles whether revenue, bookings and…BRBRBellRing BrandsLow BellRing Brands' recovery case is unproven at a $10.17 close on 10 November 2026: the October Premier Protein price increases are the repair mechanism, and the 18 November 2026 fiscal fourth-quarter report with the first fiscal 2027…BRCBBlack Rock Coffee BarLow Black Rock Coffee Bar's shares are more likely to lag the S&P 500. Third-quarter same-store sales rose 5.8%, but margins narrowed and debt rose, and fourth-quarter results, expected around March 2027, will show whether margins recover.BROSDutch BrosLow Dutch Bros still grows revenue near 30%, but customer visits rose only 0.4% in the third quarter and profit guidance was cut, so the shares are more likely to lag the S&P 500. The fourth-quarter report settles whether traffic recovers.BSINBig Sky IndustrialLow Big Sky Industrial's helium pivot is more likely to lag the S&P 500: the third-quarter report moved first production to spring 2027 and showed cash of $2.9 million, so new financing and EPA approval settle the case.BSPBending Spoons S.p.A.Low Bending Spoons' software-buying model still earns profit, but 3% organic growth and costlier debt make the shares more likely to lag the S&P 500; the 20 November 2026 Q3 report and the lock-up expiry after it settle the case.BTBTBit DigitalLow Bit Digital's shares are more likely to lag the S&P 500 over three months: revenue fell and missed, parent cash is about $5.0 million, and the shares hit a 52-week closing low of $0.66 on 13 November 2026. A turn in fourth-quarter cloud…BTDRBitdeer Technologies GroupLow Bitdeer Technologies Group is more likely to lag the S&P 500 over three months: cash of $213.7 million sits against about $1.95 billion of borrowings, and Johor slipped to 2027. Tydal Phase 1 delivery by 31 December 2026 settles whether…BTEBaytex EnergyLow Baytex Energy's crude-and-buyback story gave way to a growth plan on 5 November 2026, and the shares closed at $4.17 on 10 November 2026; delivery of 76,000-79,000 boe/d in 2027 within a C$775-850 million budget settles the case.BTGOBitGo HoldingsLow BitGo Holdings is likely to lag the S&P 500 because its third-quarter report showed core revenue shrinking and a $4.3 million adjusted EBITDA loss, even with NYDIG trading included. The fourth-quarter report shows whether operating…BTUPeabody EnergyLow Peabody Energy's shares are more likely to lag the S&P 500, since the Centurion coal mine ramp is later and costlier than planned; the fourth-quarter 2026 report shows whether it delivers 0.3–0.5 million tons.BULLWebullLow Webull Corporation's shares are more likely to lag the S&P 500 over three months while the House China-ties finding is unresolved and regulatory costs mount; the 19 November 2026 third-quarter report settles whether revenue and margin hold.BVSBioventusLow Bioventus's shares depend on its strategic review ending in a sale, and the 2 November 2026 cut to 2026 sales guidance weakens the standalone fallback; a signed deal or an end-of-review notice settles it, and the shares are more likely to…BWINBaldwin Insurance GroupLow The Baldwin Insurance Group is a signed $32.50 cash take-private, so its shares are capped near the deal price and likely to lag the S&P 500; the shareholder vote, antitrust clearance and buyout financing for a first-quarter 2027 close…CABACabaletta BioLow Cabaletta Bio's rese-cel CAR-T program is more likely to lag the S&P 500 over three months: registrational myositis results slipped to the second half of 2027, and the shares closed at $1.33 on 12 November 2026, near their $1.28 closing…CADLCandel TherapeuticsLow Candel Therapeutics' shares are more likely to lag the S&P 500 over three months: on 12 November 2026 the company pushed its prostate-cancer BLA from the fourth quarter of 2026 to mid-2027, and a filing earlier than that would show the…CAICaris Life SciencesLow Caris Life Sciences' third-quarter beat and raised 2026 revenue guidance were offset by slower 27% growth, a lower gross margin and negative free cash flow, so the shares look more likely to lag the S&P 500; the fourth-quarter report,…CALCaleresLow Caleres' brand-led earnings recovery is real but contested: Brand Portfolio sales rose 23.6% in Q2 while Famous Footwear comparable sales fell 5.9%, and Q3 guidance trails consensus. The December Q3 report settles whether the $1.50–$1.65…CBRLCracker Barrel Old Country StoreLow Cracker Barrel's shares look more likely to lag the S&P 500: the $66.13 close on 11 November 2026 tops every cited analyst target while restaurant comparable sales fell 2.1% last quarter. The first-quarter fiscal 2027 report, expected…CCCCCC Intelligent Solutions HoldingsLow CCC Intelligent Solutions' $7.75-per-share cash sale to a GTCR-led group including Elliott caps the shares near the offer, so they are more likely to lag the S&P 500; closing, expected in the first quarter of 2027, settles the case.CCSCentury CommunitiesLow Century Communities' third-quarter orders fell 4.3% and the company cut its 2026 delivery range, so the shares are more likely to lag the S&P 500; the fourth-quarter report shows whether orders and margin stabilise.CERSCerusLow Cerus Corporation's red-cell trial met its primary endpoint but the shares still fell to $1.95 on 10 November 2026; Q4 product revenue against the reaffirmed $229–231M guide, and any use of the new $150M shelf, settle the case.CEVALow Ceva, Inc. missed its third-quarter revenue guidance and cut implied 2026 growth to about 11%, so its shares are more likely to lag the S&P 500. The February 2027 fourth-quarter report shows whether the guided record quarter of about $36…CGCCanopy GrowthLow Canopy Growth's cash burn and international sales improved in the quarter reported 6 November 2026, yet the shares closed at $0.59 on 10 November 2026; the DEA judge's recommendation and a board decision on a share consolidation settle the…CGEMCullinan TherapeuticsLow Cullinan Therapeutics is more likely to lag the S&P 500 over three months: the shares closed at $10.19 on 12 November 2026, below both moving averages, even as the first-line zipalertinib filing was completed. The December CLN-978 data…CIENCienaLow Ciena Corporation's shares are more likely to lag the S&P 500 over three months: optical orders look intact, but the stock closed at $293.99 on 12 November 2026, below falling moving averages. The fiscal-fourth-quarter report, estimated…CLDXCelldex TherapeuticsLow Celldex Therapeutics has two positive Phase 3 urticaria trials and cash guided through 2028, yet its shares closed at $30.15 on 11 November 2026, below both moving averages, and look more likely to lag the S&P 500. The late-2026 atopic…CLFCleveland-CliffsLow Cleveland-Cliffs shares are more likely to lag the S&P 500: steel earnings are recovering, but Canada's Stelco dispute is unresolved after the shares rebounded to $13.14 on 11 November 2026. An Ottawa court filing or the fourth-quarter…CLFDClearfieldLow Clearfield's $43.3M backlog and $195–205M fiscal 2027 sales guide point to a rebound in revenue, but the $0.25–0.46 EPS guide shows profit is not following yet; the fiscal Q1 report in early 2027 settles it.CLMTCalumetLow Calumet's shares are more likely to lag the S&P 500: a record third quarter has not stopped the selling, and the case waits on Montana Renewables restarting in late November and reaching an 80 million gallon SAF run-rate by year-end 2026.CLPTClearPoint NeuroLow ClearPoint Neuro is more likely to lag the S&P 500 over three months: its fortunes ride on uniQure's Huntington's application, and its own 2026 revenue guide has been cut twice. The full-year report and the FDA's 1 May 2027 target date…CLSCelesticaLow Celestica is more likely to lag the S&P 500 over three months. Its AI-datacenter hardware business set a $40.0 billion 2027 revenue outlook on 26 October 2026, but the shares closed at $254.03 on 12 November 2026, still below their 50-day…CLSKCleanSparkLow CleanSpark's financed Georgia data-center lease is intact, but shares are more likely to lag the S&P 500 over three months: Texas permit risk, falling targets and falling mining output weigh. The fiscal fourth-quarter report, projected for…CLWClearwater PaperLow Clearwater Paper's paperboard price increases are reaching its sales, but Augusta mill failures and a $10–20 million fourth-quarter EBITDA guide leave the shares more likely to lag the S&P 500; the fourth-quarter report settles it.CMBTCMB.TECH NVLow CMB.TECH's record crude-tanker earnings look largely priced in after a crowded 2026 tanker rally, and the shares sit near their 200-day average; the 26 November 2026 third-quarter report shows whether disposal gains and spot rates can…CMRCCommerce.com, Inc. Series 1Low Commerce.com is more likely to lag the S&P 500 over three months: profit is rising on cost cuts while revenue fell 2.1% in the third quarter and the CFO leaves on 13 November 2026. The fourth-quarter report, expected around February 2027,…CNHCNH IndustrialLow CNH Industrial raised 2026 earnings guidance on 9 November 2026, but tariff refunds drove the beat and farm-equipment demand is still falling, so the shares are more likely to lag the S&P 500; the 2027 outlook in early February settles it.CNMDCONMEDLow CONMED Corporation's shares are more likely to lag the S&P 500 over three months: the price leans on an unconfirmed July sale report while the 28 October 2026 report trimmed organic growth guidance. A confirmed deal or the fourth-quarter…COHULow Cohu's AI-chip test business keeps beating guidance, but its shares broke down with semiconductor-equipment stocks in November 2026 and are more likely to lag the S&P 500 over three months; the fourth-quarter report due around February…COMPCompassLow Compass, Inc. is more likely to lag the S&P 500 over three months: its guide of $100–130 million Q4 adjusted EBITDA and a warning that housing has softened outweigh the Anywhere cost savings. The Q4 report settles it.COOKTraegerLow Traeger's shares still trade well ahead of a business whose third-quarter 2026 revenue fell 40.4%, so they are more likely to lag than lead. The Lowe's holiday launch and the fourth-quarter report expected around March 2027 will show…CPIXCumberland PharmaceuticalsLow Cumberland Pharmaceuticals shares are more likely to lag the S&P 500 while the ifetroban NDA for Duchenne heart disease has no date; $80.6 million of cash at 30 September 2026 settles funding, and a dated FDA submission would settle the…CRCLCircle Internet GroupLow Circle Internet Group's shares look more likely to lag the S&P 500 because USDC circulation and reserve income are shrinking while bank- and Coinbase-backed rivals build; the fourth-quarter report shows whether USDC growth resumes.CRDLCardiol TherapeuticsLow Cardiol Therapeutics is more likely to lag the S&P 500 over three months: the MAVERIC Phase III topline is guided for mid-2027, and the company has begun selling stock under a US$75 million at-the-market program. That readout settles the…CRDOCredo Technology Group HoldingLow Credo Technology's revenue is still more than doubling, but the shares are down 57.1% from the June high after a sector-wide chip rout; the fiscal second-quarter report, expected about 1 December 2026 against a $525–535 million guide,…CRSCarpenter TechnologyLow Carpenter Technology still guides fiscal 2027 operating income of $850–880 million, but sales missed and analysts cut targets, so the shares at $297.37 are more likely to lag the S&P 500; the late-January 2027 report decides it.CRTOCriteoLow Criteo's sales are still shrinking, so the shares are more likely to lag the S&P 500; the Q4 guide of $292–298 million in contribution ex-TAC, due around 15 February 2027, settles the call.CRVSCorvus PharmaceuticalsLow Corvus Pharmaceuticals' soquelitinib shares are more likely to lag the S&P 500 over three months: the Angel eczema readout slipped to March 2027, so the main test sits past the window. $202.9 million of cash funds trials into the second…CSIQCanadian SolarLow Canadian Solar's shares are more likely to lag the S&P 500 over three months: subsidiary CSI Solar's revenue fell 42.63% in the third quarter, and the parent's own third-quarter report, expected around 18 November 2026, must show a turn to…CTKBCytek BiosciencesLow Cytek Biosciences' revenue growth slowed to 2% in the third quarter and product sales fell, so the shares look more likely to lag the S&P 500 than lead it. Fourth-quarter revenue against the $208 million–$211 million outlook settles it.CTSHCognizant Technology SolutionsLow Cognizant's new-order bookings fell 7% in the third quarter and fourth-quarter revenue guidance missed estimates, so the shares are more likely to lag the S&P 500 over three months; the early-February 2027 report settles it.CVICVR EnergyLow CVR Energy's shares are more likely to lag the S&P 500 over three months: the $4.2 billion Marathon refinery purchase rests on outside funding and refining margins have faded. Closing of the deal, expected by the end of 2026, settles it.CXTCrane NXTLow Crane NXT is more likely to lag the S&P 500 over three months: third-quarter 2026 organic sales rose only 1.1% and full-year sales guidance was cut to about 14%. The fourth-quarter report with 2027 guidance, due around February 2027,…CXWCoreCivicLow CoreCivic sold four detention facilities to the federal government for $2.2 billion, still operates them, and raised recurring guidance on 4 November 2026. Two operating contracts expire in August 2027, so the shares are more likely to lag…DAVELow Dave Inc. is more likely to lag the S&P 500 over three months: the shares closed at $267.37 on 12 November 2026 despite a third-quarter beat and raised outlook, as DOJ/FTC and subpoena headlines weigh; a court ruling or the fourth-quarter…DDD3D SystemsLow 3D Systems met its Q3 revenue guidance, but a Q4 outlook below estimates, a $42.5 million share-sale program and a debt-for-equity exchange keep the shares more likely to lag the S&P 500; Q4 revenue and dilution settle it.DDOGDatadogLow Datadog beat third-quarter revenue guidance and raised its full-year forecast, but a flat fourth-quarter outlook with its largest customer at minimum commitment cut the shares to $178.40; the next quarterly report settles it.DFINDonnelley Financial SolutionsLow Donnelley Financial Solutions' shares, up 38.4% in three months to $68.68 on 11 November 2026, are more likely to lag the S&P 500 because software growth slowed to 5.0% in Q3; the Q4 report around late February 2027 settles it.DFTXDefinium TherapeuticsLow Definium Therapeutics shares are likely to lag the S&P 500: its 9 November 2026 report kept the DT120 filing on track for the first half of 2027, yet the shares fell after it. The undated fourth-quarter FDA pre-filing meeting settles the…DGIIDigi InternationalLow Digi International's shares are more likely to lag the S&P 500 over three months: the fiscal 2027 outlook slows annual recurring revenue growth from 30% to at least 15%. First-quarter fiscal 2027 results, expected in early February 2027,…DGXXDigi Power XLow Digi Power X's pivot from bitcoin mining to AI data center hosting is more likely to lag the S&P 500 over three months: Phase 1 of its Alabama campus entering service in December 2026 and the $200 million debt financing closing by about 11…DHTDHT HoldingsLow DHT Holdings shares look more likely to lag the S&P 500 despite record fourth-quarter tanker bookings, because investors are pricing a 2027 rate decline. DHT's first-quarter 2027 bookings, due in its January update and February report,…DINOHF SinclairLow HF Sinclair's record $54.22-a-barrel third-quarter refining margin has the shares, which closed at $98.76 on 10 November 2026 as post-election policy risk and easing diesel cracks hit refiners. Fourth-quarter diesel margins and fuel-rule…DJTTrump Media & Technology GroupLow Trump Media's shares are more likely to lag the S&P 500: the core business is tiny and a roughly $1 billion convertible-note put falls due 30 November 2026, ahead of the 14 December 2026 vote on the TAE Technologies merger.DKDelek US HoldingsLow Delek US Holdings is more likely to lag the S&P 500 over three months: its record third-quarter earnings of 6 November 2026 rest on peak refining margins, and fourth-quarter margins and weekly distillate stocks decide whether they hold.DLTRDollar TreeLow Dollar Tree's multi-price earnings recovery is real, but the shares, at $141.27 on 12 November 2026, sit above the $140 targets of Evercore ISI and Loop Capital, so they are more likely to lag the S&P 500 over three months. The 24 November…DNAGinkgo Bioworks HoldingsLow Ginkgo Bioworks' third-quarter revenue recovered to $27.7 million but is still 6% below a year earlier, and the shares are more likely to lag the S&P 500; fourth-quarter revenue against that $27.7 million figure settles it.DNTHDianthus TherapeuticsLow Dianthus Therapeutics' shares are more likely to lag the S&P 500 than lead it over three months, because the case rests on one binary event: the Phase 2 MoMeNtum readout of claseprubart in multifocal motor neuropathy, guided to December…DOCSDoximityLow Doximity's shares are more likely to lag the S&P 500 because AI spending has cut profit while revenue growth sits at 4%; the fiscal third-quarter report, expected in early February 2027, shows whether growth reaches the guided 6%.DOCUDocuSignLow DocuSign shares are more likely to lag the S&P 500: at $80.15 they sit above September analyst targets while revenue grows about 9%. The early-December fiscal third-quarter report must show Intelligent Agreement Management tracking toward…DPRODraganflyLow Draganfly's third-quarter 2026 report pushed its defense-driven growth into 2027, so the shares are more likely to lag the S&P 500; priced Canadian or U.S. defense orders reaching revenue would change that.DSGNDesign TherapeuticsLow Design Therapeutics' shares are more likely to lag the S&P 500: a new $200 million stock-sale program adds supply while DT-216P2's regulatory path is unconfirmed; the company's Q4 2026 registrational-plans update settles it.DSGRDistribution Solutions GroupLow Distribution Solutions Group's shares are more likely to lag the S&P 500 over three months: they trade on a $35.00 cash buyout from LKCM Headwater, which caps upside. The definitive proxy and the unaffiliated-holder vote, due before the 31…DSXDiana ShippingLow Diana Shipping is re-fixing ships at much higher charter rates, but the shares sit below their 50-day and 200-day averages and are more likely to lag the S&P 500; the 25 November 2026 third-quarter report shows whether revenue confirms the…DTILPrecision BioSciencesLow Precision BioSciences' hepatitis B gene-editing data held up in full, but with no clinical result due before Phase 2 dosing in early 2027 the shares are more likely to lag the S&P 500. Year-end 2026 Duchenne safety data is the next dated…DUOTDuos Technologies GroupLow Duos Technologies is more likely to lag the S&P 500 over three months because its 20 MW, 10-year colocation contract deploys only from Q2 2027; the 16 November 2026 third-quarter report shows whether 2026 revenue nears the above-$50…DYNDyne TherapeuticsLow Dyne Therapeutics' shares are more likely to lag the S&P 500 over three months: the case rests on the FDA's 21 January 2027 decision on zeleciment rostudirsen in Duchenne and the Q1 2027 myotonic dystrophy topline, with cash funded into Q2…EDITEditas MedicineLow Editas Medicine's shares look more likely to lag the S&P 500 over three months: its 9 November 2026 report puts human efficacy data in the second half of 2027, so only first dosing and early safety data fall in the window.EDRYEuroDryLow EuroDry's shares are more likely to lag the S&P 500 despite a third-quarter earnings beat, because nine of its eleven ships reset charters in November and December 2026 into a softer dry-bulk market. The fourth-quarter charter rates those…EFOREverforthLow Everforth's shares look more likely to lag the S&P 500: Q3 2026 revenue beat guidance, but consulting orders slowed and Q4 guidance centers below consensus. The Q4 report, expected around 3 February 2027, shows whether federal awards…EFXEquifaxLow Equifax shares are more likely to lag the S&P 500 over the next three months: the October rebound already prices in 8% non-mortgage growth, and FHFA's pending bi-merge ruling and the February 2027 guidance settle the case.EFXTEnerflexLow Enerflex's shares are more likely to lag the S&P 500 over three months: TD Cowen expects new US engine orders to pause over Texas permitting. The mid-December Texas grid audit and fourth-quarter bookings settle whether its record $2.136…EGOEldorado GoldLow Eldorado Gold's shares are more likely to lag the S&P 500 over three months: they fell three sessions to $31.84 (close, 12 November 2026) after a 2026 gold guidance cut and higher costs. Commercial production at Skouries and McIlvenna Bay…ELEElemental RoyaltyLow Elemental Royalty's third-quarter sales missed forecasts and Orion debt lifted leverage to about 2.5 times EBITDA, so the shares are more likely to lag the S&P 500. The Generation sale and a Caserones recovery in fourth-quarter results…ENPHEnphase EnergyLow Enphase Energy's core residential business is shrinking faster than its transformer pivot can offset, so the shares are more likely to lag the S&P 500; the fourth-quarter 2026 report, guided at $225–255 million, settles it.ENVAEnova InternationalLow Enova International's shares are more likely to lag the S&P 500 after breaking below their September low on 6 November 2026, despite a third-quarter growth beat and a new $500 million buyback; fourth-quarter charge-offs against the third…EOLSEvolusLow Evolus is more likely to lag the S&P 500 over three months: third-quarter revenue growth slowed to 13% from 21% and cash is thin. The FDA decision on Evolysse Sculpt, expected by 31 December 2026, settles whether growth re-accelerates.EPCEdgewell Personal CareLow Edgewell Personal Care's shares are more likely to lag the S&P 500 over three months: the fiscal 2027 outlook sits on analyst estimates and the price is under a rejected $30 bid. The first fiscal 2027 quarterly report, expected around…EPRXEupraxia PharmaceuticalsLow Eupraxia Pharmaceuticals' once-a-year EoE steroid injection, EP-104GI, is priced on open-label data from 14 patients, and the shares have rallied into a 13 November 2026 Analyst Day. The December 2026 placebo-controlled Phase 2b interim…EQNREquinor ASALow Equinor's earnings follow European gas and oil prices, which fell in early November on Iran peace-talk hopes, so the shares are more likely to lag the S&P 500 over three months; the Visund restart and the fourth-quarter report due around 4…ERASErascaLow Erasca's pan-RAS drug ERAS-0015 faces a binary test in the 20 November 2026 oral presentation of more pancreatic cancer patients; with the Revolution Medicines patent dispute open, the shares are more likely to lag the S&P 500 than lead it.ESTCElasticLow Elastic's shares are more likely to lag the S&P 500 despite 21% contract growth, after a director's October share sales and a slide below the 50-day average; the 19 November 2026 second-quarter report settles whether revenue confirms the…EXFYExpensifyLow Expensify's total revenue is still falling (third quarter $33.0 million, down 6%), so its shares are more likely to lag the S&P 500 until New Expensify growth lifts the top line; the fourth-quarter report settles it.EXKEndeavour SilverLow Endeavour Silver cut lower its 2026 production guide and raised cost guidance even as Q3 unit costs fell, with silver below its Q3 realized price, so the shares are likely to lag the S&P 500; the January 2027 Q4 production release settles…FACFactorial EnergyLow Factorial Energy's shares are more likely to lag the S&P 500, as third-quarter 2026 revenue was only $26 thousand and meaningful sales wait for 2027; the fourth-quarter report shows whether orders gain disclosed value.FBINFortune Brands InnovationsLow Fortune Brands Innovations is more likely to lag the S&P 500 over three months: Water sales fell 5.5% in the third quarter and 2026 earnings guidance was cut on 3 November 2026; the fourth-quarter report, expected in late February 2027,…FCELFuelCell EnergyLow FuelCell Energy's data-center power case still has no firm order behind it beyond an initial 30 MW, and the shares are more likely to lag the S&P 500; the fiscal fourth-quarter report due in December settles it.FDMT4D Molecular TherapeuticsLow 4D Molecular Therapeutics' gene therapy 4D-150 has no controlled efficacy data yet, so the shares are more likely to lag the S&P 500 until the randomized 4FRONT-1 wet AMD topline guided for the second quarter of 2027, while cash fell to…FETForum Energy TechnologiesLow Forum Energy Technologies beat third-quarter profit estimates, but flat fourth-quarter guidance and drilling orders below revenue leave the shares more likely to lag the S&P 500; the fourth-quarter report, estimated for late February 2027,…FIGFigmaLow Figma's revenue beat and raised guidance, but gross margin and net dollar retention both fell as AI credits got cheaper, so the shares are more likely to lag the S&P 500 over three months. The fourth-quarter report, expected around…FIVNFive9Low Five9's AI revenue is growing about 91%, but a profit guidance cut and a $325 million cash purchase of Level AI make the shares more likely to lag the S&P 500 over three months; the fourth-quarter report, around February 2027, shows…FLXSFlexsteel IndustriesLow Flexsteel Industries' shares are more likely to lag the S&P 500 over three months: first-quarter margin of 6.0% missed the 6.5% to 7.0% guide, which is repeated for the second quarter. The late-January 2027 report settles it.FORMFormFactorLow FormFactor's shares are more likely to lag the S&P 500: they closed at $95.78 on 11 November 2026, down 27.3% in three months despite a beat-and-raise quarter. Fourth-quarter revenue against the $275–$295 million guide, due around 4…FOURShift4 PaymentsLow Shift4 Payments' growth recovery stalled on 5 November 2026 (organic growth 9%, guidance cut again), so the shares are more likely to lag the S&P 500; the early-2027 fourth-quarter report decides whether record cash flow and buybacks carry…FRDFriedman IndustriesLow Friedman Industries' record September quarter is already reflected in a share price that fell after the report, so the shares are more likely to lag the S&P 500 over three months; the December-quarter report settles whether steel margins…FRNMFreenomeLow Freenome's shares are rated more likely to lag the S&P 500: its 10 November 2026 report showed $430.0 million of cash, but $180.0 million of $183.5 million quarterly revenue was a one-off Abbott collaboration payment. The December 2026…FROFrontlineLow Frontline's shares look more likely to lag the S&P 500 over the next three months because crude-tanker spot rates roughly halved in the week to 12 November 2026. The third-quarter report on 20 November 2026 shows how much of October's rate…FSLRFirst SolarLow First Solar's third-quarter report cut 2026 sales guidance, left backlog at 44.0 GW and showed new US bookings near $0.36 per watt, so the case now rests on the $0.38 import price floor starting 4 December 2026 lifting prices.FSLYFastlyLow Fastly's security-led growth beat and raised in Q3 (revenue $190.2M), yet the shares have fallen after three straight reports and are more likely to lag the S&P 500; the Q4 report around February 2027 settles whether growth holds near 20%.FSMFortuna MiningLow Fortuna Mining's shares are more likely to lag the S&P 500: third-quarter cost rose to $2,286 per gold equivalent ounce and the shares trade with falling gold. The Diamba Sud permit, expected in Q4 2026, settles the case.FTKFlotek IndustriesLow Flotek Industries' shares look more likely to lag the S&P 500 over the next three months: international chemistry drove a third 2026 guidance raise, but Data Analytics revenue slipped to $18.1 million and the Q4 report falls after that…FTNTFortinetLow Fortinet's firewall refresh still lifts product sales and billings, but its 28 October 2026 service-revenue guidance cut drove the shares to $123.57; fourth-quarter billings against the $2.775–2.925 billion guide settle whether the case…FWDIForward IndustriesLow Forward Industries holds the largest listed Solana treasury, 8,727,694 SOL on 9 November 2026, but SOL sits near a three-month low and debt has risen to $187.5 million, so the shares are more likely to lag the S&P 500. The fiscal 2026…GCOGenescoLow Genesco's margin-led turnaround is working, but flat comparable sales and an 8% inventory build leave the shares more likely to lag the S&P 500 than lead it; the early-December Q3 fiscal 2027 report decides it.GCTSGCT Semiconductor HoldingLow GCT Semiconductor's third-quarter revenue of $1.069 million missed estimates and management pushed the 5G chipset ramp into the first half of 2027, so the shares are more likely to lag the S&P 500; fourth-quarter revenue and 5G purchase…GDRXGoodRx HoldingsLow GoodRx is more likely to lag the S&P 500 over three months: its 2 November 2026 restatement and late filing leave its numbers unverified, and the September-quarter 10-Q due by the extension's end on 14 November 2026 decides it.GERNGeronLow Geron Corporation's case now rests on RYTELO in lower-risk MDS, which grew to $60.1 million in the third quarter, up about 27% on the year; the fourth-quarter report and stock-sale dilution at about $0.97 a share settle it.GGALGrupo Financiero GaliciaLow Grupo Financiero Galicia's US-listed shares are more likely to lag the S&P 500 over three months because Argentine sovereign risk, not bank earnings, drives them; October inflation of 2.2% beat forecasts, and third-quarter results (~24…GHGuardant HealthLow Guardant Health's Shield revenue is growing fast, but patent losses, wider cash-burn guidance and a new $500 million convertible note sale make the shares more likely to lag the S&P 500; the report expected around 18 February 2027 settles…GHRSGH ResearchLow GH Research's shares are more likely to lag the S&P 500 over three months: they trade just above the $18.00 April 2026 offering price with no dated pivotal-trial start, and the third-quarter report, estimated for 20 November 2026, is the…GLUEMonte Rosa TherapeuticsLow Monte Rosa Therapeutics' Novartis milestones now fund its business, but the MRT-8102 heart-disease test, GFORCE-2, is guided only for H1 2027. Until it starts and reads out, shares trade on milestones, spending and start dates.GLWCorningLow Corning's shares are more likely to lag the S&P 500 as AI-infrastructure stocks sell off, even with fiber sales up 44% in Q3 2026; the Q4 report around 27 January 2027 is the next test.GLXYGalaxy DigitalLow Galaxy Digital's shares are more likely to lag the S&P 500 over three months: they trade below both moving averages and most Q3 profit came from trading gains, not rent. The fourth-quarter 2026 report, expected in February 2027, shows…GOGOLow Gogo's Galileo satellite service is growing fast and its loan now runs to 2030, but business aviation revenue fell 10% in the third quarter, so the shares are more likely to lag the S&P 500; the fourth-quarter report, expected around March…GOLFAcushnet HoldingsLow Acushnet Holdings, maker of Titleist and FootJoy, is more likely to lag the S&P 500 over three months: third-quarter sales fell 1.3% and the 2026 profit guide leans on about $30 million of tariff refunds. The late-February 2027…GPRKGeoparkLow GeoPark's Venezuela Bare contract is in force, but third-quarter margins and cash flow fell and the shares are more likely to lag the S&P 500. Crude differentials in Colombia and the Gilinski tender at $12.22 settle the case.GRPNGrouponLow Groupon is more likely to lag the S&P 500 over three months: third-quarter adjusted EBITDA of $14.7 million missed the $19–21 million guide, free cash flow was negative $45.8 million and full-year revenue guidance fell. The 8 December 2026…GSHDGoosehead InsuranceLow Goosehead Insurance shares are more likely to lag the S&P 500 over three months: the company expects to report material weaknesses, its restated financials and third-quarter 10-Q are unfiled, and the amended filings settle the case.GTMZoomInfo TechnologiesLow ZoomInfo's AI-agent repositioning has not reached its numbers: third-quarter 2026 revenue fell 2.9% to $308.8 million and net revenue retention slipped to 88%, so the shares are more likely to lag the S&P 500. A disclosed agent revenue…GWREGuidewire SoftwareLow Guidewire Software's $1.7 billion hyperexponential deal gives its AI story a growth figure, but the shares are more likely to lag the S&P 500 over three months; the early-December report shows whether organic ARR holds $1,450–1,460 million.HBBHamilton Beach Brands HoldingLow Hamilton Beach Brands is more likely to lag the S&P 500 over three months: it cut its 2026 revenue and operating-profit outlook on 4 November 2026 as retailers turned cautious on holiday orders. Holiday sell-through from 27 November 2026…HCCWarrior Met CoalLow Warrior Met Coal's shares are more likely to lag the S&P 500: Blue Creek volume is up 48%, but sales at about 66% of the benchmark coal price keep earnings below forecasts. Fourth-quarter volume and price realization settle it.HELPCybinLow Helus Pharma (formerly Cybin) is more likely to lag the S&P 500 over three months: the shares rest on one Phase 3 depression trial, APPROACH, guided to report in the fourth quarter of 2026, and a miss or a slip past 31 December 2026…HGTYHagertyLow Hagerty's shares are more likely to lag the S&P 500 over three months because its majority holder sold 11.5 million shares in the November 2026 offering, its second sale in two months, after a raised 2026 outlook; the fourth-quarter…HIMXHimax TechnologiesLow Himax Technologies' shares are more likely to lag the S&P 500 over three months: it guided Q4 2026 revenue down 22–26% on an automotive order cut, and the Q4 report, expected around February 2027, shows whether the setback is temporary.HIVEHIVE Digital TechnologiesLow HIVE Digital Technologies' AI cloud revenue grew to $8.8 million in the quarter ended 30 September 2026, but bitcoin mining still supplied $76.0 million and the quarter's loss was $78.7 million, so the shares are more likely to lag the S&P…HLHecla MiningLow Hecla Mining's record third-quarter cash flow has not lifted the shares, which closed at $14.12 on 11 November 2026. A new 50-million-share stock sales program and the Keno Hill curtailment make a lag behind the S&P 500 more likely;…HMYHarmony Gold MiningLow Harmony Gold's shares are more likely to lag the S&P 500 over three months: September-quarter gold output fell 12% and earnings lean on gold near $4,040 an ounce. The 9 December 2026 Federal Reserve decision is the next test.HOVHovnanian EnterprisesLow Hovnanian Enterprises' shares are more likely to lag the S&P 500: they closed at $98.01 on 11 November 2026, down 28.1% in three months, and the early-December fiscal fourth-quarter report decides whether backlog converts into guided…HPEHewlett Packard EnterpriseLow Hewlett Packard Enterprise's shares look more likely to lag the S&P 500 as memory costs and data-center policy risk reprice AI hardware. The 23 November 2026 fiscal fourth-quarter report shows whether networking and Helios orders become…HPKHighPeak EnergyLow HighPeak Energy's shares are more likely to lag the S&P 500: a third-quarter beat came with a $55.7 million net loss on hedges, and free cash flow fell short of the quarter's debt payment. The refinancing closing, which the company expects…HPPHudson Pacific PropertiesLow Hudson Pacific Properties is more likely to lag the S&P 500: occupancy and guidance improved in the 5 November 2026 report, yet the shares fell to $8.64 by 11 November 2026. The fourth-quarter report shows whether occupancy and cash…HROWHarrowLow Harrow, the eye-care drugmaker, is more likely to lag the S&P 500 over three months: it cut its 2026 adjusted profit outlook by more than half on 9 November 2026. The fourth-quarter results, due around March 2027, show whether revenue…HTLDHeartland ExpressLow Heartland Express is more likely to lag the S&P 500 over three months: its third-quarter 2026 operating ratio was 98.7% against 91.0% in the second quarter, and the fourth-quarter report, expected around February 2027, shows whether…HTZHertz Global HoldingsLow Hertz Global Holdings is more likely to lag the S&P 500: its best operating quarter in three years left $17.9 billion of debt ahead of shareholders, and the 1 December 2026 bond maturity and any extension terms decide whether the equity is…HUTHut 8Low Hut 8's shift from bitcoin miner to AI data-center landlord, with about $19.6 billion of contracted Beacon Point leases, is more likely to lag the S&P 500 over three months; the Texas grid decision expected around 17 December 2026 settles…HVTHaverty Furniture CompaniesLow Haverty Furniture Companies' shares are more likely to lag the S&P 500 over three months: order growth slowed to 2.3% in the third quarter from 12.3%, and adjusted EPS ex-refunds was $0.25. The early-2027 fourth-quarter report settles it.HZOMarineMaxLow MarineMax trades as a pending $53.00-per-share cash takeover by Safe Harbor Marinas, which caps the shares near their price and makes them likelier to lag the S&P 500. The filed vote result and a closing on or after 7 December 2026 settle…IARTIntegra LifeSciences HoldingsLow Integra LifeSciences' shares are more likely to lag the S&P 500 over three months: 2026 guidance held, but fourth-quarter guidance missed estimates. The SurgiMend relaunch targeted for 31 December 2026 and the Cincinnati plant's 2027…IBKRInteractive Brokers GroupLow Interactive Brokers' shares are more likely to lag the S&P 500 over three months: October trading was 4% below a year earlier and client equity fell 4% from September. The November metrics, due around 1 December 2026, show whether both…ICHRIchor HoldingsLow Ichor Holdings' shares are more likely to lag the S&P 500 over three months: third-quarter operating cash flow was negative $28.8 million and inventory rose, even though customer Applied Materials reported record revenue on 12 November…IDYAIDEAYA BiosciencesLow IDEAYA Biosciences is more likely to lag the S&P 500: its Phase 3 OptimUM-010 trial closed on poor enrollment and brokers cut targets after the 3 November 2026 report. FDA acceptance of darovasertib and the IDE849 Phase 3 starts settle the…IESCIES HoldingsLow IES Holdings' data-center electrical backlog is real, but the shares closed at $177.32 on 11 November 2026, 56.6% below the 52-week high, and are more likely to lag the S&P 500. The fiscal fourth-quarter report, expected near 20 November…IHRTiHeartMediaLow iHeartMedia's shares are likely to lag the S&P 500 after it cut 2026 Adjusted EBITDA guidance to $550–600 million from about $800 million on 9 November 2026, with $4.68 billion of net debt; the fourth-quarter report in early 2027 shows…IKTInhibikase TherapeuticsLow Inhibikase Therapeutics' IKT-001 for pulmonary arterial hypertension is funded, with $193.3M cash on 30 September 2026, but dilution and warrant-dependent runway weigh on shares at $1.55; 2027 interim safety data is next.ILMNIlluminaLow Illumina's shares are more likely to lag the S&P 500 over the next three months: third-quarter organic growth was 4.8%, China sits outside the clinical growth rate, and on 10 November 2026 management declined to guide 2027. The…IMMXImmix BiopharmaLow Immix Biopharma's CAR-T therapy NXC-201 has strong interim data, but the shares are more likely to lag the S&P 500 while they trade below both 2026 offering prices; the 14 December 2026 ASH presentation settles whether the 89% response…IMOSChipMOS TECHNOLOGIESLow ChipMOS's profit is rising with memory demand, but its US shares closed at $48.25 on 10 November 2026, 42.1% below the 52-week high; November monthly revenue, due around 10 December 2026, tests whether the record third quarter holds.IMRNImmuronLow Immuron Limited's strategic review, announced 10 November 2026 with LifeSci Capital, lifted shares to $0.93, but the company says no deal is assured; the shares are still more likely to lag the S&P 500 until terms are disclosed.IMRXImmuneeringLow Immuneering's atebimetinib is still a single-arm pancreatic-cancer story, and the randomized MAPKeeper 301 trial, guided to mid-2028, settles it. The third-quarter report moved cash runway to the fourth quarter of 2028, from 2029.INBXInhibrx BiosciencesLow Inhibrx Biosciences' head-and-neck drug ordastobart led pembrolizumab alone on response rate (48.3% vs 26.5%, 8 September 2026), but the shares are more likely to lag the S&P 500; the Q3 report's financing and Phase 3 timing settle it.INDIindie SemiconductorLow indie Semiconductor's third-quarter core revenue met its target, but about $430 million of debt and GAAP losses leave the shares more likely to lag the S&P 500; fourth-quarter core revenue against the roughly $47 million guide settles it.INFQInfleqtionLow Infleqtion's neutral-atom quantum hardware and government-funded work are real, but the shares closed at $9.35 on 10 November 2026, 52.9% below the 52-week high; the third-quarter report on 16 November 2026 decides whether revenue confirms…INGNInogenLow Inogen's shares are more likely to lag the S&P 500 after its first report as a pure oxygen-concentrator maker showed revenue down 2.4% and a lower outlook, leaving a new CEO's $20 million cost program to carry the case. The fourth-quarter…INHDInno HoldingsLow Inno Holdings is a low-conviction recovery case resting on reported cash of $33,238,616 at 30 June 2026, but the shares closed at $2.51 on 10 November 2026, below the September low; the fiscal 2026 annual report, due around 29 December…INODInnodataLow Innodata is more likely to lag the S&P 500 over three months: third-quarter revenue rose 53% to $95.6 million, but a large customer program ended in mid-October and margins fell; the fourth-quarter report, expected around 26 February 2027,…INSPInspire Medical SystemsLow Inspire Medical Systems is more likely to lag the S&P 500 over three months: revenue fell 7.9% in the third quarter and 2026 guidance was only narrowed. The fourth-quarter report, expected around February 2027, settles whether the decline…INSWInternational SeawaysLow International Seaways' record third-quarter profit has up its share price as tanker spot rates ease from their peak, so the shares are more likely to lag the S&P 500 over three months; spot rates and the 23 December 2026 dividend settle it.INTAIntappLow Intapp's shares look more likely to lag the S&P 500: Celeste AI drew over 40% of fiscal Q1 2027 net new bookings, yet cloud ARR growth slowed to 28% and contracted revenue fell to $799.4 million. The early-February 2027 report shows…INTRInterLow Inter & Co.'s shares are more likely to lag the S&P 500 over three months: profit grew 26% in the 12 November 2026 report, but late overdue loans rose to 5.3% and Brazilian rates and the real set the price. The fourth-quarter report,…IOVAIovance BiotherapeuticsLow Iovance Biotherapeutics' shares are more likely to lag the S&P 500 than lead it: a third-quarter Amtagvi sales beat on 5 November 2026 met an 11% one-day fall, and the lung case now rests on a biomarker subgroup. Full-year 2026 revenue…IPXIperionXLow IperionX's titanium-powder output rose to 8.7 tons in the September quarter, but it reported no fiscal 2026 revenue and Titan mine financing is unsecured, so the shares are more likely to lag the S&P 500; the cash report due around 30…IQiQIYILow iQIYI's shares are more likely to lag the S&P 500 over three months: revenue is shrinking, its micro-drama, AI and overseas pivot has no reported revenue line, and the 16 November 2026 third-quarter report shows whether that changes.IRDMIridium CommunicationsLow Iridium Communications trades as a claim on Rocket Lab's $27.00 cash-plus-stock offer, so its upside is capped and the shares are more likely to lag the S&P 500; the FCC license-transfer decision and Rocket Lab's price against the $67.50…ITGartnerLow Gartner's contract value is growing too slowly (2.5% at 30 September 2026) to lift the shares, which are more likely to lag the S&P 500; the fourth-quarter report, expected in early February 2027, shows whether growth reaches 3%.ITGRInteger HoldingsLow Integer Holdings' shares are more likely to lag the S&P 500 over three months: KKR's $127.00 cash price caps the gain. Completion, which the company targets by 31 December 2026, settles the outcome.ITUBItau Unibanco HoldingLow Itaú Unibanco still earns a 23.6% return on equity, in line with forecasts, but its US shares trade on Brazil's fiscal risk and sit at $7.39, level with 28 October 2026; the fourth-quarter report and Lula's economic team settle the case.IVAInventivaLow Inventiva's shares are more likely to lag the S&P 500 over three months: funding is conditional and the lanifibranor MASH result is a coin flip on a single asset. The undated fourth-quarter 2026 NATiV3 topline settles the call.JBHTJ.B. Hunt Transport ServicesLow J.B. Hunt's shares are more likely to lag the S&P 500 over three months: third-quarter operating income rose 2% on 20% revenue growth, and fuel-excluded intermodal pricing rose 2%. The 2027 contract bid season settles whether margins…JBLUJetBlue AirwaysLow JetBlue Airways is more likely to lag the S&P 500: lenders holding about 55% of its 2031 bonds and first-lien loan signed a cooperation pact on 11 November 2026, and $8.4 billion of debt meets $4.64-a-gallon fuel; financing news or…JILLJ.JillLow J.Jill's earnings recovery is largely reflected in the price, so the shares lean toward lagging the S&P 500 until the third-quarter report, expected around 9 December 2026, shows whether guided 3%–5% sales growth arrives.JOBYJoby AviationLow Joby Aviation's shares lean toward lagging the S&P 500 over three months: the third-quarter revenue beat is Blade air-charter income, and initial U.S. passenger operations moved to 2027. Dubai flight testing by year-end 2026 and FAA flight…JWELJowell GlobalLow Jowell Global, a China-based online seller of supplements and cosmetics, is more likely to lag the S&P 500 over three months: the shares closed at $1.73 on 12 November 2026, down 44.0% in three months, with no filing behind the August…KCKingsoft Cloud HoldingsLow Kingsoft Cloud's shares are more likely to lag the S&P 500: AI-cloud billings and a first operating profit have not stopped a 25.3% three-month fall; the 24 November 2026 Q3 report shows whether the profit repeats.KEELKeel InfrastructureLow Keel Infrastructure, the former Bitfarms bitcoin miner, is more likely to lag the S&P 500 over three months: it has no signed data-center lease and withdrew its 2026 lease goal on 5 November 2026. A first signed lease settles the case.KELYAKelly ServicesLow Kelly Services' shares are more likely to lag the S&P 500 over three months: the company cut its fourth-quarter outlook on 5 November 2026, and the fourth-quarter report, expected around February 2027, shows whether the 3.8%–4.0% margin…KEYSKeysight TechnologiesLow Keysight Technologies' record AI-network test orders back the business, but the shares are more likely to lag the S&P 500 over three months after a 22.0% fall from the high; the 19 November 2026 report on revenue and fiscal 2027 guidance…KGSKodiak Gas ServicesLow Kodiak Gas Services shares are more likely to lag the S&P 500: they fell to $42.26 on 10 November 2026 after a third-quarter beat and raised guidance, and four brokers cut targets. A second signed data-center power contract, or on-time…KLCKinderCare Learning CompaniesLow KinderCare Learning Companies is more likely to lag the S&P 500 over three months: its 12 November 2026 report cut 2026 adjusted EBITDA guidance to $190–195 million, and the shares fell about 25% after hours. Management's March 2027…KMXCarMaxLow CarMax's 3 November 2026 Shift into GEAR plan holds profit per car flat rather than restoring it, so earnings growth must come from volume, costs and buybacks. The quarter ending 30 November 2026 is the first results test; the shares look…KODKEastman KodakLow Eastman Kodak is more likely to lag the S&P 500 over three months: third-quarter Advanced Materials & Chemicals revenue fell to $99 million from $105 million, and the fourth-quarter report, expected around March 2027, settles it.KOSKosmos EnergyLow Kosmos Energy is more likely to lag the S&P 500 over three months: the 2 November 2026 report missed estimates and fourth-quarter output is guided down to 60,000–64,000 boepd. Fourth-quarter results and year-end net debt below $2.4 billion…KROKronos WorldwideLow Kronos Worldwide's third-quarter titanium-dioxide profit recovery is real, but management guided to a softer fourth quarter and debt is $539.9 million, so the shares are more likely to lag the S&P 500 over three months; fourth-quarter…KRTKarat PackagingLow Karat Packaging's 33.5% third-quarter gross margin missed the 35–37% guide and fourth-quarter guidance is lower at 33–35%, so the shares look more likely to trail the S&P 500. Freight costs and the 1 January 2027 price increase settle it.KURAKura OncologyLow Kura Oncology's KOMZIFTI sales rose 53% to $13.9 million in the third quarter of 2026. Even so, a new shelf filing and a cut to 2026 collaboration-revenue guidance leave the shares more likely to lag the S&P 500, and ASH data in December…KYMRKymera TherapeuticsLow Kymera Therapeutics' shares are more likely to lag the S&P 500 because the price already reflects a clear win for oral eczema drug KT-621; the Phase 2b BROADEN2 topline, guided by year-end 2026, settles whether efficacy nears Dupixent's.LARLithium ArgentinaLow Lithium Argentina is more likely to lag the S&P 500 over three months: its third-quarter realized lithium price of $17,580 per tonne fell below the $18,000 Stage 2 base case. The year-end PPG approval target and the 15 January 2027 note…LEGNLegend BiotechLow Legend Biotech's shares are more likely to lag the S&P 500 after the 10 November 2026 report, which showed a profit but slowing CARVYKTI growth and drew four target cuts. Anito-cel's 23 December 2026 FDA decision and fourth-quarter sales…LFSTLifeStance Health GroupLow LifeStance Health shares are more likely to lag the S&P 500 over the next three months because holders keep selling into the profit upturn, including 45 million shares at $13.12 on 9 November 2026. The fourth-quarter report, estimated for…LGIHLGI HomesLow LGI Homes shares lean toward lagging the S&P 500 over three months: third-quarter net orders fell 61.2% to 609 and the post-report rise has reversed. The November closings release, expected around 3 December 2026, shows whether demand is…LILALiberty Latin AmericaLow Liberty Latin America's shares are more likely to lag the S&P 500 over three months: the 4 November 2026 quarterly report missed estimates and the Liberty Puerto Rico restructuring is unresolved. A signed deal on the parent's stake in the…LNCLincoln NationalLow Lincoln National Corporation's capital is improving but earnings are not: third-quarter adjusted earnings of $1.72 a share missed the $1.96 consensus, so the shares are more likely to lag the S&P 500. The fourth-quarter report settles it.LOVELovesacLow Lovesac's shares are more likely to lag the S&P 500 over three months after the 10 September 2026 guidance cut; the third-quarter report, expected around 10 December 2026, settles whether results hold inside the lowered guide.LPGDorian LpgLow Dorian LPG shares are more likely to lag the S&P 500 over three months because its record gas-carrier rates rest on a largely shut Strait of Hormuz that US-Iran talks could reopen. The December-quarter forward booking release, expected…LSTRLandstar SystemLow Landstar System is more likely to lag the S&P 500 over three months: third-quarter truck revenue per load rose about 25%, but earnings of $1.42 per share missed on $21 million of claims costs, and Morgan Stanley cut its target to $130 on…LTRXLantronixLow Lantronix shares are more likely to lag the S&P 500 after investors sold a fiscal first-quarter 2027 beat down to a $4.39 close on 10 November 2026; a disclosed drone revenue figure and the February fiscal second-quarter report settle…LUXELuxExperience B.V.Low LuxExperience, the luxury e-commerce group behind Mytheresa and NET-A-PORTER, is slightly more likely to lag the S&P 500 over three months after a 38.7% rally; the 17 November 2026 first-quarter report decides whether results justify the…LZLegalZoom.comLow LegalZoom's cost cuts are holding profit up while subscription units shrink; the 4 November 2026 report cut FY2026 adjusted EBITDA guidance to $180–185 million, and Q4 results decide whether customer acquisition stabilises.MMacy'sLow Macy's shares are more likely to lag the S&P 500 over three months: operations are improving (second-quarter comparable sales rose 2.7%), but a guided third-quarter loss and a price above consensus targets leave little cushion. The report…MAMAMama's CreationsLow Mama's Creations is growing fast (revenue up 55% in the July 2026 quarter), but its shares are more likely to lag the S&P 500 over three months, closing at $13.24 on 12 November 2026. Gross margin and a use for the cash settle it at the…MANManpowerGroupLow ManpowerGroup's recovery case is unconfirmed: October temporary hiring rebounded, but BofA and BNP Paribas cut the shares to Neutral on 3 November 2026, and the fourth-quarter report decides whether the $1.03–$1.13 EPS guide holds.MARAMARA HoldingsLow MARA Holdings is more likely to lag the S&P 500 over three months: its debt is repaid, but no artificial-intelligence tenant has signed. Management's 31 December 2026 target for two leases, which it says may slip into 2027, settles the…MASS908 DevicesLow 908 Devices' shares are more likely to lag the S&P 500 despite a third-quarter beat, because the market sold the 10 November 2026 report and the 2026 outlook implies fourth-quarter growth of about 20%. The 2027 outlook due early in 2027…MATMattelLow Mattel's 2026 guidance cut on 5 November 2026 leaves an unconfirmed Authentic Brands takeover approach as the main support for the shares, which look more likely to lag the S&P 500; a confirmed offer, a sale process or the February 2027…MATVMativ HoldingsLow Mativ Holdings is repairing its debt but not its margins, so its shares are more likely to lag the S&P 500; the fourth-quarter report, expected around 26 February 2027, shows whether the 12.5% adjusted EBITDA margin recovers.MAZEMaze TherapeuticsLow Maze Therapeutics' kidney drug MZE829 has an early efficacy signal and cash guided into 2029, but the shares are more likely to lag the S&P 500: full HORIZON data slipped to early 2027 and the shares have already rallied.MCHPMicrochip TechnologyLow Microchip Technology is more likely to lag the S&P 500 over three months: its 5 November 2026 outlook guides December-quarter sales down 3% to up 1% with lower gross margin, and the early-February 2027 report settles whether growth resumes.MDBMongoDBLow MongoDB's shares are more likely to lag the S&P 500 over three months: its cloud database grew 30% last quarter, but it has had no permanent CEO since 28 September 2026. The 1 December 2026 third-quarter report is the next test.MEIMethode ElectronicsLow Methode Electronics is more likely to lag the S&P 500: an unexplained 23.4% one-day fall on 5 November 2026 has only partly reversed, and the fiscal second-quarter report, estimated for about 2 December 2026, decides whether the $72–$82M…MESOMesoblastLow Mesoblast's cell therapy Ryoncil grew 44% from a year earlier but fell to US$28 million from US$36 million in June, so the shares are more likely to lag the S&P 500; the report for the December 2026 quarter, due around January 2027,…MGMMGM Resorts InternationalLow MGM Resorts International is more likely to lag the S&P 500 over three months: third-quarter adjusted EBITDA fell to $403 million from $506 million. The Nevada October gaming report in late November tests management's claim of an October…MGNXMacroGenicsLow MacroGenics' B7-H3 cancer drug MGC026 showed head-and-neck responses, but shares are more likely to lag the S&P 500: third-quarter revenue fell to $18.7 million and the next MGC026 data is not due until mid-2027.MGTXMeiraGTx HoldingsLow MeiraGTx's shares are more likely to lag the S&P 500 over three months: the US filing for its gene therapy bota-vec slipped to the first quarter of 2027, and the December 2026 European submission is the next test.MKTXMarketAxess HoldingsLow MarketAxess Holdings' fixed $167 cash sale to Intercontinental Exchange caps the shares' upside, so they are more likely to lag the S&P 500 over three months; the remaining non-US approvals and the first-quarter 2027 closing settle it.MLKNMillerKnollLow MillerKnoll's recovery hinges on orders turning into sales, and the shares are more likely to lag the S&P 500 than lead it; the fiscal second-quarter report, expected around 17 December 2026, shows whether sales reach guidance.MMEDMiniMed GroupLow MiniMed Group's diabetes-device sales grew 15.8% organically in the July quarter, but the shares ($17.88 close on 12 November 2026, below the $20.00 IPO price) are more likely to lag the S&P 500; the 24 November 2026 fiscal second-quarter…MMYTMakeMyTripLow MakeMyTrip's shares rebounded to $51.60 on 10 November 2026 with no new results; 20.9% constant-currency bookings growth sits against a 2.5% revenue rise and falling air demand, and the late-January 2027 report settles it.MNPRMonopar TherapeuticsLow Monopar Therapeutics' Wilson disease drug ALXN1840 keeps an open FDA path, but the shares are more likely to lag the S&P 500 over three months. Completion of the New Drug Application, guided on 12 November 2026 to within several weeks, and…MNTNLow MNTN, Inc.'s shares are more likely to lag the S&P 500 over three months: a sales-force overhaul cut third-quarter revenue to $80.251 million and full-year guidance to $311–314 million. The fourth-quarter 2026 report, expected in early…MOVMovado GroupLow Movado Group's margin recovery is already in reported results, and the shares, down 10.5% in three months, are more likely to lag the S&P 500; the third-quarter fiscal 2027 report, expected in late November, tests the 55%–56% margin…MPCMarathon PetroleumLow Marathon Petroleum's shares are more likely to lag the S&P 500 because a record $45.70-a-barrel third-quarter refining margin did not stop a post-report slide; the fourth-quarter report, expected in early February 2027, shows whether…MQMarqetaLow Marqeta's revenue growth is slowing to 3–5% and Cash App issuance will shrink further in 2027, so the shares are more likely to lag the S&P 500; the 2027 outlook due in February settles whether gross profit growth recovers.MRAMEverspin TechnologiesLow Everspin Technologies is more likely to lag the S&P 500 over three months: record third-quarter revenue of $20.6 million did not stop a 31.6% three-month fall, and legal costs keep GAAP results negative. The hearing before an…MRXMarex GroupLow Marex Group's profit is growing fast, but the shares are more likely to lag the S&P 500: the Q3 margin slipped to 23.7% and net interest income fell. The fourth-quarter report, estimated for early 2027, settles whether both turn up.MTHMeritage HomesLow Meritage Homes' shares are more likely to lag the S&P 500 over three months: the early-November rate rebound has reversed to $64.80 on 12 November 2026, and third-quarter orders fell 15% with no guidance. Builder sentiment around 17…MTSIMACOM Technology Solutions HoldingsLow MACOM beat its fiscal fourth-quarter guide and guided fiscal first-quarter revenue to $450–460 million, yet the shares are more likely to lag the S&P 500 over three months. The chip group is in a bear market and book-to-bill cooled to 1.4;…MXMagnachip SemiconductorLow Magnachip Semiconductor's shares are more likely to lag the S&P 500 over three months: fourth-quarter gross margin is guided to 10%–12% from 14.0%, and the fourth-quarter report, expected around February 2027, shows whether that is the low.MXLMaxLinearLow MaxLinear's shares are more likely to lag the S&P 500 over three months: guidance is strong, but the stock trades with a volatile optical group; the fourth-quarter report, expected around 28 January 2027, decides it.MYEMyers IndustriesLow Myers Industries' shares are more likely to lag the S&P 500 over three months: third-quarter gross margin fell to 27.3% from 34.3% on resin costs. The fourth-quarter report, expected around late February 2027, settles whether the promised…NABLN-ableLow N-able is more likely to lag the S&P 500 over three months: it cut full-year recurring-revenue guidance a second time on 5 November 2026, and 33 N-central exploits published on 8 November 2026 put its core product's trust at issue. The…NATNordic American TankerLow Nordic American Tankers' shares are more likely to lag the S&P 500 because Atlantic suezmax spot rates fell 29–52% in the week to 6 November 2026. The 30 November 2026 third-quarter report and dividend show whether fourth-quarter bookings…NAVNNavanLow Navan's shares are more likely to lag the S&P 500 than lead it over three months: they closed at $26.20 on 12 November 2026, 15.2% below the August high, with no new results since September. The fiscal third-quarter report, expected around…NBTXNanobiotixLow Nanobiotix shares are more likely to lag the S&P 500 over the next three months because the Phase 3 NANORAY-312 head and neck cancer readout that decides the case has no date. Cash runs into 2029, so news on that trial's timing or result…NEOGNeogenLow Neogen's shares are more likely to lag the S&P 500 into early 2027: they broke below their post-results low on 12 November 2026 as the Zoetis Genomics sale that funds debt reduction slipped to early 2027. The fiscal second-quarter report…NESRNational Energy Services ReunitedLow National Energy Services Reunited, a Middle East and North Africa oilfield-services provider, is more likely to lag the S&P 500 over three months: third-quarter revenue fell 3.1% and cash flow turned negative. The fourth-quarter report,…NEXANexa ResourcesLow Nexa Resources, a zinc producer, is more likely to lag the S&P 500 over three months: its shares track Boliden's pending purchase of the controlling holder, and Citigroup cut its target to $12 on 12 November 2026. Boliden's 23 November…NGNENeurogeneLow Neurogene's Rett syndrome gene therapy NGN-401 is funded into the first quarter of 2029, but the shares are more likely to lag the S&P 500 over three months: they closed at $23.90 on 12 November 2026, through the kill line. The Embolden…NIQNIQ Global IntelligenceLow NIQ Global Intelligence's shares are more likely to lag the S&P 500: its debt goal is met, but organic growth is stuck at 5.8%. The fourth-quarter report, expected around 26 February 2027 with a 2027 outlook, shows whether growth speeds up.NKTRNektar TherapeuticsLow Nektar Therapeutics is more likely to lag the S&P 500 over three months: the shares closed flat at $37.27 on 13 November 2026 after the third-quarter report, and alopecia durability doubts remain. The 24-week off-treatment alopecia data,…NNENano Nuclear EnergyLow NANO Nuclear Energy's shares are more likely to lag the S&P 500 over three months: they closed at $11.09 on 12 November 2026, and its agreements are non-binding. The 30 November 2026 business update webcast, following the annual report,…NOGNorthern Oil and GasLow Northern Oil and Gas is more likely to lag the S&P 500 over three months: record third-quarter results and higher production guidance did not hold the shares, which follow crude and U.S.-Iran headlines. Fourth-quarter results, expected…NOKNokiaLow Nokia's AI data-center sales are growing fast, but negative cash flow and a cut cash-conversion target make the shares more likely to lag the S&P 500 over three months; the fourth-quarter report, expected around 29 January 2027, settles…NRIXNurix TherapeuticsLow Nurix Therapeutics is more likely to lag the S&P 500 over three months: Sanofi ended its STAT6 program on 3 November 2026 and the shares are down 42.3% in three months. The bexobrutideg poster at the ASH meeting on 13 December 2026 decides…NTAPNetAppLow NetApp's flash-storage growth and raised fiscal-2027 outlook support its AI-storage case, but Barclays and Guggenheim tie much of the gain to memory-price pass-through, so the shares are more likely to lag the S&P 500 over three months.…NUTXNutex HealthLow Nutex Health's third-quarter cost cut came in smaller than guided and earnings fell from a year earlier, so the shares are more likely to lag the S&P 500; the fourth-quarter results and the two hospital openings decide it.NVAXNovavaxLow Novavax raised its 2026 adjusted revenue framework to $385–415 million on 5 November 2026, but the lift is mostly the known $125 million Sanofi milestone, and the shares closed at $9.98 on 11 November 2026, below pre-report levels.…NVCRNovoCureLow NovoCure's core glioblastoma business beat and raised in the third quarter, but the FDA's 9 November 2026 Not Approvable letter for Optune Mya removes a 2027 brain-metastases launch; the outcome of the company's talks with the FDA settles…NVCTNuvectis PharmaLow Nuvectis Pharma's shares are more likely to lag the S&P 500 over three months: NXP200 glioma data are out, and the remaining test is whether US IND filings for NXP100 and NXP200 land by the 31 December 2026 guide.NVECNVELow NVE Corporation's shares are more likely to lag the S&P 500 over three months: September-quarter product sales of $5,575,282 were half June's $10,734,735. The fiscal third-quarter report, expected around January 2027, settles whether…NWLNewell BrandsLow Newell Brands' turnaround now has two straight quarters of core-sales growth, but the full-year cash-flow forecast was cut to about $150M and the shares have already rebounded; the fourth-quarter report decides whether growth and…NWPXNWPX InfrastructureLow NWPX Infrastructure beat third-quarter estimates with record $179.4M revenue, but signed water-pipe backlog fell to $264M and the shares closed at $91.68; the fourth-quarter report in early 2027 shows whether new awards replace the…NXHBed Bath & BeyondLow Neighborhood Intelligence (formerly Bed Bath & Beyond) is more likely to lag the S&P 500: third-quarter revenue growth was mostly acquired and the company still loses money. The 2027 revenue target of $2.0 billion to $2.1 billion and the…NXPINXP SemiconductorsLow NXP Semiconductors' automotive and industrial recovery is confirmed (Q3 revenue $3.786B), but in-line Q4 guidance, analyst targets of $245 to $350 and a reported Ambarella deal leave the shares range-bound; the next quarterly report…OBIOOrchestra BioMed HoldingsLow Orchestra BioMed is more likely to lag the S&P 500 over three months: the BACKBEAT hypertension data that decide the case are planned for the Heart Rhythm 2027 meeting in May 2027, after that window, and the shares are up 39.5% in three…OCCOptical CableLow Optical Cable Corporation's data-center-driven sales and margin growth is real, but its order book stopped growing in the July quarter and the shares sit below their 50- and 200-day averages, so they are more likely to lag the S&P 500. The…ODFLOld Dominion Freight LineLow Old Dominion Freight Line's recovery is not yet being paid for: the shares closed at $168.02 on 10 November 2026 after a Q3 beat and a round of target cuts. The early-December operating update settles whether tonnage and pricing hold.OGNOrganonLow Organon & Co. trades as a completion case on Sun Pharma's $14.00 cash acquisition; the $13.85 close on 9 November 2026 sits just under the offer, and the 3 December 2026 European Commission deadline and remaining clearances settle it.OIIOceaneering InternationalLow Oceaneering International's shares fell to a $35.06 close on 10 November 2026 as fourth-quarter EBITDA guidance of $85–95 million outweighs a $430–480 million 2027 outlook; the report due around February 2027 is the first test.OKTALow Okta's shares are more likely to lag the S&P 500 because index-addition buying has passed and no reported figure shows AI-agent products lifting contracted revenue. The 1 December 2026 third-quarter report tests contracted-revenue growth…OMDAOmada HealthLow Omada Health beat and raised on 5 November 2026, yet the shares fell 20.37% on 6 November 2026 and closed at $15.09 on 9 November 2026, because revenue growth slowed to 34% and 2027 is unquantified. The fourth-quarter report and 2027…OMEROmerosLow Omeros Corporation is more likely to lag the S&P 500 over three months: Europe upheld its rejection of YARTEMLEA on 16 October 2026, leaving one US product, and the 16 November 2026 third-quarter report must show net product sales well…OOMALow Ooma's shares are more likely to lag the S&P 500 over three months: they trade below the 50-day average, and the raised fiscal 2027 revenue outlook of $332.0–333.5 million faces its test when Ooma reports on 1 December 2026 after the close.OPENOpendoor TechnologiesLow Opendoor Technologies is more likely to lag the S&P 500 over three months: its 3.3% third-quarter margin met the cut outlook, but it guided a fourth-quarter adjusted EBITDA loss of $70–85 million. The fourth-quarter results decide whether…ORBSEightco HoldingsLow Eightco Holdings closed at $0.72 on 9 November 2026, below $1.00, against roughly $399 million of company-stated holdings as of 28 October 2026; the third-quarter report, expected about 13 November 2026, and the Worldcoin token price…ORICOric PharmaceuticalsLow Oric Pharmaceuticals' enozertinib has a stated Phase 3 path, but the shares are more likely to lag the S&P 500 over three months: they closed at $8.50 on 12 November 2026, and third-quarter cash and dilution decide whether they recover.OTEXOpen TextLow Open Text Corporation is more likely to lag the S&P 500 over three months: first-quarter revenue fell 4.0% and second-quarter guidance sits below the analyst estimate. The 10 February 2027 Investor Day framework settles whether revenue…OTLYOatly Group ABLow Oatly Group AB's shares are more likely to lag the S&P 500 over three months: the 28 October 2026 cut of 2026 adjusted EBITDA guidance to $16–20 million from $25–35 million undercut the turnaround, and the fourth-quarter report decides…OXMOxford IndustriesLow Oxford Industries' fiscal 2026 adjusted earnings guidance of $1.60–$2.00 a share sits below its $2.80 annual dividend, even after the shares rebounded to $30.43; the third-quarter report near 10 December 2026 settles whether the payout…PEverpureLow Everpure's shares look more likely to lag than lead the S&P 500: storage stocks are selling even strong results, and the shares fell 16.4% on 5 November 2026. The 18 November 2026 third-quarter report settles whether results back the…PACBPacific Biosciences of CaliforniaLow Pacific Biosciences' shares are more likely to lag the S&P 500 after Q3 2026 showed gross margin falling to 33% from 41% and a guide cut to $155–160M, followed by a $100M at-the-market stock program. The fourth-quarter report, expected in…PAGSPagSeguro DigitalLow PagSeguro Digital's shares are more likely to lag the S&P 500, with payments growth stalled, overdue loans rising and Citigroup and UBS at Neutral with $8 targets. The 16 November 2026 third-quarter report tests whether volume and credit…PATHUiPathLow UiPath's shift from robotic-process automation to AI agent orchestration has not yet lifted company-wide growth, so the shares are more likely to lag the S&P 500 over three months; the fiscal third-quarter report on 3 December 2026 settles…PAYPaymentus HoldingsLow Paymentus, the bill-payment processor, is more likely to lag the S&P 500 over three months: third-quarter revenue growth slowed to 19.8% despite a profit beat, and the fourth-quarter report, expected near late February 2027, settles…PAYOPayoneer GlobalLow Payoneer Global is a pending $7.40-per-share all-cash takeout by Nuvei; the shares trade just below that price, so the remaining gain is small, and regulatory clearance and completion, targeted for mid-2027, settle the case.PAYSPaysignLow Paysign's shares are more likely to lag the S&P 500 over three months because the loss of 113 plasma centers outweighs its third-quarter beat. The fourth-quarter report, expected in early March 2027, shows whether new copay programs and…PBFPBF EnergyLow PBF Energy's record third-quarter earnings look priced in, so the shares are more likely to lag the S&P 500 over three months; weekly distillate inventory reports from 18 November 2026 and Russian diesel arrivals show whether margins hold.PBIPitney BowesLow Pitney Bowes is lifting earnings through cost cuts, debt reduction and buybacks while revenue is flat to down, but the shares fell to $15.40 after a beat; the fourth-quarter report, expected around late February 2027, settles the…PBRPetroleo Brasileiro S.A.-PetrobrasLow Petrobras shares are more likely to lag the S&P 500 after a third-quarter dividend below bank forecasts and higher 2026 capital-spending guidance. The 2027–2031 strategic plan, due on 23 November 2026, shows whether payouts recover.PCTPureCycle TechnologiesLow PureCycle Technologies' recovery case failed its test: third-quarter output was 5.2 million pounds, below the 8.4-million-pound first-quarter record, and revenue missed badly on 4 November 2026. Fourth-quarter output and Thailand financing…PDFSPDF SolutionsLow PDF Solutions' third-quarter Platform revenue grew 22% and the 20% growth target stands, but backlog fell to $247.2 million, so the shares stay a modest lagging case until year-end backlog is reported.PDSPrecision DrillingLow Precision Drilling's rig recovery is real but largely reflected in its shares, which face no company report before about 11 February 2027, so they are more likely to lag the S&P 500 over three months; that fourth-quarter report settles…PENGPenguin SolutionsLow Penguin Solutions' AI-memory growth case is intact on the numbers, with fiscal 2027 guidance affirmed on 4 November 2026 and SK Hynix now a 9.1% holder, but the shares closed at $45.70 on 9 November 2026 on financing and inventory worries.…PGENPrecigenLow Precigen's PAPZIMEOS is now profitable and cash-generating, but quarterly growth slowed to 37% and a rival RRP drug was approved, so the shares are more likely to lag the S&P 500 over three months; fourth-quarter revenue settles it.PLPlanet Labs PBCLow Planet Labs' shares are more likely to lag the S&P 500 over three months: third-quarter guidance of $101–105 million sits under consensus and contracted work is shrinking. The report after the close on 10 December 2026 settles it.PLAYDave & Buster's EntertainmentLow Dave & Buster's shares are a thin residual claim behind about $1.5 billion of debt, with its term loans quoted near 60 cents on the dollar on 4 November 2026; lender terms and the December third-quarter report decide what is left for…PLPCPreformed Line ProductsLow Preformed Line Products' grid-equipment demand is real, but the shares are more likely to lag the S&P 500 over three months: Q3 2026 sales of $209.5 million missed the $215.0 million estimate. The fourth-quarter report, expected around…PLTKPlaytika HoldingLow Playtika Holding Corp.'s takeover case ended on 5 November 2026 when the Board closed its strategic review with no deal; record adjusted EBITDA of $252.1 million meets falling paying users and a revolver due March 2027, and the refinancing…PNRGPrimeEnergy ResourcesLow PrimeEnergy Resources looks more likely to lag the S&P 500 than lead it: crude fell to $86.85 on 9 November 2026 and the earnings repair needs gas revenue to turn positive. The third-quarter report, estimated for 16 November 2026, settles…POWLPowell IndustriesLow Powell Industries' shares are more likely to lag the S&P 500 over three months: the record $2.4 billion backlog has not yet shown up in revenue, and the shares are down 33.6% in three months. The fiscal fourth-quarter report after the…PPTAPerpetua ResourcesLow Perpetua Resources' case rests on closing its $2.9 billion EXIM loan and announcing a construction decision by 31 December 2026; the mid-November third-quarter report is the next check on cash, and no closing has been announced.PRGOPerrigoLow Perrigo's shares are more likely to lag the S&P 500 after the 4 November 2026 cut to 2026 core earnings guidance of $2.15–$2.35 a share; the Infant Formula sale brings only $40 million upfront against about $3.3 billion of debt. The Oral…PRGSProgress SoftwareLow Progress Software's Domo purchase lifted its fiscal 2026 revenue outlook, but a weaker fourth-quarter earnings guide and revolver-funded debt leave the case unproven; the fiscal fourth-quarter report, expected around mid-January 2027,…PRLBProto LabsLow Proto Labs' shares are more likely to lag the S&P 500 over three months: record third-quarter revenue was offset by a 44.5% gross margin, and the fourth-quarter report in late February 2027 shows whether margins recover.PRPOPrecipioLow Precipio's shares are more likely to lag the S&P 500 after a jump to $24.80 on 11 November 2026, because third-quarter revenue of $7.331 million showed steady growth with no new acceleration. The fourth-quarter report, expected around…PRTHPriority Technology HoldingsLow Priority Technology Holdings trades as a pending $8.05-per-share cash buyout, so upside is capped near the offer and the S&P 500 is more likely to lead; the unaffiliated-shareholder vote and regulatory approvals, guided for the first half…PSXPhillips 66Low Phillips 66 still looks more likely to lag the S&P 500 over three months: the shares carry a war premium that crude's November slide is eroding. Whether the diesel crack spread holds above its $64 one-year average settles it.PTENPatterson-UTI EnergyLow Patterson-UTI Energy's drilling recovery is real, but its shares are more likely to lag the S&P 500 over three months: they closed at $10.67 on 12 November 2026, 20.3% below the September high, and Citigroup cut its target to $11. The…PURRHyperliquid StrategiesLow Hyperliquid Strategies, which holds the HYPE token, is more likely to lag the S&P 500 over three months: its shares trade below token value (0.93x on 6 November 2026), pausing share sales; the early-February 2027 report shows if buybacks…PVHLow PVH Corp.'s brand reset at Calvin Klein and Tommy Hilfiger rests on delivering $11.80–$12.10 of fiscal 2026 adjusted EPS without tariff-refund help; the Q3 report, due in early December, settles it.QLYSQualysLow Qualys shares look more likely to lag the S&P 500 over three months because the company guided fourth-quarter billings growth down to about 8% from 14%; its fourth-quarter report, expected around 5 February 2027, shows whether that is…QSIQuantum-SiLow Quantum-Si's shares still price in more than its Proteus protein sequencer has delivered: launch is guided for Q2 2027, and 2026 revenue for about $1.0M. The company's all-20-amino-acid target, due by year-end 2026, is the next test.QTRXQuanterixLow Quanterix's third-quarter report beat on revenue but cut the year-end cash forecast to about $70 million and pushed the spatial panels to early 2027, so the shares still lack a result that supports a recovery; the fourth-quarter report…QUBTQuantum ComputingLow Quantum Computing Inc. is more likely to lag the S&P 500: third-quarter 2026 revenue of $9.5 million came at a 4.5% gross margin, with growth credited to acquisitions, and backlog fell to $39.1 million. Proof of Dirac-3S shipments and of…QUIKQuickLogicLow QuickLogic's shares are more likely to lag the S&P 500 over three months: third-quarter revenue of $5.138 million missed estimates, and the $8 million fourth-quarter guide needs a 55% jump from contracts not yet closed; the fourth-quarter…QUREuniQureLow uniQure's Huntington's gene therapy AMT-130 cleared the FDA filing stage with priority review and a 1 May 2027 decision date, yet the shares still closed at $22.71 on 10 November 2026; the advisory committee decides whether the weakened…RAPPRapport TherapeuticsLow Rapport Therapeutics' RAP-219 beat placebo in bipolar mania by 3.1 points, short of management's 4-point bar, but cash is guided through 2029; fourth-quarter 2026 seizure safety data decide whether tolerability concerns spread.RBLXRobloxLow Roblox Corporation beat its Q3 bookings guide ($1.697 billion) but daily users fell 9% year over year and Q4 bookings are guided down 10–15%; the Q4 report in early 2027 shows whether users stabilise.RBRKRubrikLow Rubrik shares look more likely to lag the S&P 500 after the November security-software sell-off, despite 33% subscription ARR growth; the 30 November 2026 fiscal third-quarter report decides whether a guidance raise brings buyers back.RCKTRocket PharmaceuticalsLow Rocket Pharmaceuticals' shares are more likely to lag the S&P 500 over three months: the Danon gene therapy trial reports no efficacy until mid-2028, and first KRESLADI patient onboarding, guided for the fourth quarter of 2026, is the next…RCKYRocky BrandsLow Rocky Brands' sales are growing fast, but 2026 profit leans on tariff gains that will not recur, so the shares look more likely to lag the S&P 500 than lead it; the 2027 guidance due with fourth-quarter results in late February 2027…RCMTRCM TechnologiesLow RCM Technologies is more likely to lag the S&P 500 over three months: Engineering revenue fell to $30.7 million in the quarter to 3 October 2026, below the second quarter's $39.5 million. The fiscal 2026 year-end report, expected around…RDACRising Dragon AcquisitionLow Rising Dragon Acquisition Corp., a blank-check company with no operating business, is more likely to lag the S&P 500 over three months: its HZJL merger ended on 30 October 2026 and no new target is named. The 15 November 2026 extension…RDWRedwireLow Redwire Corporation's shares are more likely to lag the S&P 500 over three months: a record $619.7 million backlog has not yet produced profit, and third-quarter revenue missed estimates. The fourth-quarter report, expected around March…RFAIRF Acquisition Corp IILow RF Acquisition Corp II, a blank-check shell awaiting its Nanyang Biologics merger, is more likely to lag the S&P 500 over three months: the price rests on a small float from 98.95% preliminary redemptions, and the closing report with final…RLYBRallybioLow Rallybio's stockholders approved the Avenzo Therapeutics merger on 4 November 2026 and the final cash distribution is $13.90 per share, so what remains is a roughly 2.8% stake in an early-stage oncology company. The merger closing after…RMBSRambusLow Rambus's server-memory chip growth is real, but the shares are more likely to lag the S&P 500 over three months: they closed at $84.97 on 12 November 2026, under the 50-day and 200-day averages. Nvidia's 17 November 2026 report and…ROGRogersLow Rogers Corporation's engineered-materials recovery is real, but the shares are more likely to lag the S&P 500 over three months: the fourth-quarter guide steps down and data-center revenue is not expected before the second half of 2027.RPAYRepay HoldingsLow Repay Holdings' Q3 report on 9 November 2026 beat estimates, but the core consumer segment grew 0.3% organically and growth and cash-conversion targets were cut. The 7 December 2026 Investor Day shows whether management can restore the…RUMRumbleLow RUM Group, formerly Rumble, is more likely to lag the S&P 500 over three months: third-quarter revenue beat the guide, but the $13.7 billion Maysville contract is being reworked and has no financing. A disclosed funding package or a signed…RVMDRevolution MedicinesLow Revolution Medicines' shares are more likely to lag the S&P 500 over three months: they closed at $176.35 on 12 November 2026, and the fourth-quarter RASONQUE report, expected about February 2027, shows if the $197.6 million first quarter…RXRXRecursion PharmaceuticalsLow Recursion Pharmaceuticals' shares look more likely to lag the S&P 500 over three months: cash runs into 2029 and REC-4881 data held up, but every dated next step sits in 2027. An FDA agreement on the registrational trial settles the case.RXTRackspace TechnologyLow Rackspace Technology's shares are more likely to lag the S&P 500: about $610 million of new AI contracts announced 10 November 2026 lack secured GPU financing while dilution widens. The year-end AMD installation and a signed financing…SSentinelOneLow SentinelOne shares are more likely to trail the S&P 500 than lead it over three months: net new annual recurring revenue grew only 4% at Q2, and the early-December Q3 report decides whether AI-security products change that.SAFTSafety Insurance GroupLow Safety Insurance Group's shares closed at $104.49 on 10 November 2026, below Mapfre's fixed $105.00 cash offer. Shareholders approved the deal on 3 November 2026, so Massachusetts insurance regulator approval now settles the outcome.SAHSonic AutomotiveLow Sonic Automotive's shares are more likely to lag the S&P 500 over three months: third-quarter 2026 adjusted earnings per share of $1.30 missed the $1.67 estimate and franchised-dealership income fell 22%. The fourth-quarter report,…SANASana BiotechnologyLow Sana Biotechnology's type 1 diabetes case rests on one patient's result, and the shares are more likely to lag the S&P 500 over three months; the SC451 IND filing and trial start, guided "as early as this year" on 5 November 2026, settles…SATLSatellogicLow Satellogic's shares are more likely to lag the S&P 500 because its record third quarter rested on satellite sales while recurring data revenue slipped and operating profit turned to a loss. Merlin commissioning results and delivery of the…SBETSharpLinkLow SharpLink, Inc. avoided MSCI index deletion on 11 November 2026, but its shares are more likely to lag the S&P 500 because they trade at 0.71 times their Ether's value and that discount keeps widening; Ether's direction and the discount…SBSLow Sabesp's ADS are more likely to lag the S&P 500 over three months: third-quarter net income fell 35.7% on financing costs, and the shares trade below their 200-day average. Lula's term on 5 January 2027 tests federal policy toward the…SCZMSantacruz Silver MiningLow Santacruz Silver's case as a larger Bolivian silver producer remains weakened: Q3 silver output fell 5% and the shares closed at $7.57 on 10 November 2026; the Q3 financial results (listed for 13 November 2026) show whether revenue tops…SESeaLow Sea Limited's Q3 report on 10 November 2026 beat on revenue and showed Shopee profit rising, but Monee's bad-loan ratio rose to 1.3% and EPS missed, so a rebound from $76.80 is unproven. The Q4 report, due around March 2027, settles…SEERLow Seer, Inc. closed at $1.61 on 10 November 2026 after its board rejected both take-private proposals and the third-quarter report cut 2026 revenue guidance to $13.5-14.5 million. Cash of $198.1 million and the year-end patent ruling now…SFIXStitch FixLow Stitch Fix's shares are more likely to lag the S&P 500 over three months: active clients fell to 2.277 million at 1 August 2026 and fiscal 2027 revenue guidance implies flat sales. The early-December first-quarter report tests whether the…SHAKShake ShackLow Shake Shack's shares are more likely to lag the S&P 500 over the next three months: the 5 November 2026 report held full-year ranges, but margin sits in the lower half of its range and 2027 has no outlook. Fourth-quarter results due around…SHLSShoals Technologies GroupLow Shoals Technologies' third-quarter beat and raised 2026 revenue guide are now overshadowed by its 4 November 2026 all-stock merger with ARRAY Technologies, which makes the shares a claim on the combined company; shareholder votes and a Q1…SHOOSteven MaddenLow Steven Madden beat third-quarter earnings and raised its full-year profit outlook, but the shares fell after the 5 November 2026 report because Kurt Geiger growth slowed and the guide implies a flat fourth quarter. The next test is the…SIDUSidus SpaceLow Sidus Space is more likely to lag the S&P 500 over three months: on 12 November 2026 its restatement widened to eight reporting periods back to the third quarter of 2024, with no date for corrected filings. The third-quarter Form 10-Q, due…SITCSITE CentersLow SITE Centers, a liquidation stub after its $3.00 payout, is more likely to lag the S&P 500 over three months: it has not said what it will still distribute, and the 4 December 2026 NYSE delisting and The Blocks sale closing settle the read.SKMSK TelecomLow SK Telecom's ADRs are more likely to lag the S&P 500 over three months: AI data-center sales grew only 6.2% in the third quarter, so the case rests on its Anthropic stake, priced when trading is expected to open 19 November 2026.SKWDSkyward Specialty Insurance GroupLow Skyward Specialty Insurance Group is more likely to lag the S&P 500 over three months: the third-quarter combined ratio of 89.9% held, but premium growth is slowing and property pricing is falling. The 2027 guidance with fourth-quarter…SKYASkyAILow SkyAI's shares are more likely to lag the S&P 500 over three months. They closed at $2.45 on 12 November 2026, below the $3.00 cash tender that expired that night, and the untendered shares' value rests on the cash left after payment.SLDBSolid BiosciencesLow Solid Biosciences' Duchenne gene therapy SGT-003 is more likely to lag the S&P 500 over three months: the Food and Drug Administration (FDA) Type C meeting in late 2026 and its minutes decide whether accelerated approval stays open.SMSM EnergyLow SM Energy's Civitas merger is cutting debt, but a lowered 2026 oil outlook and flat 2027 volumes leave the shares tied to crude and more likely to lag the S&P 500; fourth-quarter results and 2027 guidance, expected in February 2027, settle…SMTCSemtechLow Semtech's shares are more likely to lag the S&P 500 over three months: they closed at $119.44 on 12 November 2026, down 14.9%, despite a raised outlook. The report after the close on 23 November 2026 settles whether sales and data-center…SMTISanara MedTechLow Sanara MedTech is more likely to lag the S&P 500 over three months: its sale to MiMedx has no closing date after the FTC's 15 October 2026 Second Request, and the 12 November 2026 guidance cut weakens the fallback value. FTC clearance or a…SMWBSimilarwebLow Similarweb's pivot to licensing its web-traffic data for AI has disclosed contract value but not yet clear recurring revenue, and the shares are more likely to lag the S&P 500. The Q3 report on 17 November 2026, the first under new CEO…SNAPLow Snap Inc.'s profit recovery is real, but 4% advertising growth and falling North American users make the shares more likely to lag the S&P 500 over three months; the fourth-quarter 2026 report, expected around February 2027, settles it.SNDRSchneider NationalLow Schneider National's earnings are improving, but its shares are more likely to lag the S&P 500 over three months: they closed at $28.95 on 12 November 2026, below both moving averages, after brokers cut targets. Freight data and the…SNDXSyndax PharmaceuticalsLow Syndax Pharmaceuticals is more likely to lag the S&P 500 over three months: Revuforj sales are growing, yet the shares are down 51.9% in three months. The frontline leukemia data at ASH on 13 December 2026 and 14 December 2026 settle it.SNEXStoneX GroupLow StoneX Group's earnings are still growing sharply year over year, but the shares sit 38.8% below their 52-week high after a sequential revenue drop. Fiscal Q4 net operating revenue against the $719.7 million of Q3 settles whether earnings…SNPSSynopsysLow Synopsys' AI chip-design growth plan and fiscal 2027 revenue guide of $11.1–11.2 billion still stand, and the shares have recovered to $466.97. The fourth-quarter report on 8 December 2026 decides whether the guide holds.SOPHSOPHiA GENETICS SALow SOPHiA GENETICS' third-quarter report showed healthy customer spending but held its revenue range at the upper end of $94–96 million, so the shares are more likely to lag the S&P 500; the fourth-quarter report decides it.SPIRSpire GlobalLow Spire Global's third quarter cut cash use to $5.0 million but missed revenue and trimmed 2026 guidance to $75–80 million, so the shares are more likely to lag the S&P 500; the fourth-quarter report shows whether the guided $23–28 million…SPRYARS PharmaceuticalsLow ARS Pharmaceuticals, a one-product company selling the needle-free epinephrine spray neffy, is more likely to lag the S&P 500 over three months: third-quarter revenue missed estimates and no new insurance coverage has arrived. The…SPSCSPS CommerceLow SPS Commerce's shares are more likely to trail the S&P 500 over the next three months: 2026 revenue guidance fell twice and the reported GTCR takeover talks remain unconfirmed. A signed deal or the 2027 outlook settles it.SPTSprout SocialLow Sprout Social's profit recovery is outrunning its revenue, so the shares are more likely to lag the S&P 500: the 3 November 2026 report raised fiscal 2026 earnings guidance but guided fourth-quarter revenue below consensus. The…SPXCSPX TechnologiesLow SPX Technologies' cooling backlog passed $1.1 billion, but a cut to 2026 HVAC margin guidance leaves the shares below both moving averages and more likely to lag the S&P 500 over three months; the fourth-quarter report, expected around…SRPTSarepta TherapeuticsLow Sarepta Therapeutics is more likely to lag the S&P 500 over three months: ELEVIDYS sales fell to $83.5 million in the third quarter of 2026 from $98.1 million, and the fourth quarter is guided flat. The RNA data guided for late 2026 are…SRZNSurrozenLow Surrozen's cash now runs into 2029, but the shares at $31.88 already carry that news; with the resale registration for $11.60 placement stock due about 19 November 2026, they are more likely to lag the S&P 500 than lead it.SSLSasolLow Sasol Limited's shares are more likely to lag the S&P 500 over three months: the ADR is 21.2% below its October high and the fiscal 2026 recovery is priced in; interim results due around 23 February 2027 test net debt against US$3 billion.SSRMSSR MiningLow SSR Mining's third-quarter report on 3 November 2026 missed estimates and lifted the cost warning to about 10% above the top of 2026 guidance, so the buyback-and-Nevada story is lagging; the Roxmore closing and next costs decide it.SSTISoundThinkingLow SoundThinking's shares are more likely to lag the S&P 500 over three months because Transom Capital Group's $8.00-cash-plus-CVR tender offer caps the upside; the 17 November 2026 tender expiry decides whether holders receive it.STAASTAAR SurgicalLow STAAR Surgical's third-quarter report showed China demand holding up (underlying China sales +31%) but supply and gross margin still lagging; the shares closed at $23.87 on 10 November 2026, and the fourth-quarter report decides whether…STLNStarling OncologyLow Starling Oncology's shares are more likely to lag the S&P 500 after it cut 2026 capitated revenue to about $110 million from $150 million and a 10% owner sold 2.85 million shares; the fourth-quarter report, expected around March 2027,…STNEStoneCoLow StoneCo's shares are more likely to lag the S&P 500 over three months: its over-90-day loan-loss ratio rose to 9.92% in the third quarter and adjusted gross profit fell 8.0%, despite a raised 2026 earnings outlook. Brazil's late-January…STROSutro BiopharmaLow Sutro Biopharma's shares are more likely to lag the S&P 500 over three months: cash fell to $142.2 million at 30 September 2026, Merck ended MK-1484 on 7 November 2026, and the next STRO-004 data update is guided to the first half of 2027.STTKShattuck LabsLow Shattuck Labs' DR3-blocking antibody SL-325 has no patient efficacy data until the first half of 2028, and the shares closed at $4.99 on 9 November 2026 after the Q3 report; the Phase 2 trial starts decide the next step.STUBStubHub HoldingsLow StubHub Holdings is likely to lag the S&P 500: third-quarter margins jumped and debt fell, but sales grew only 7% and analysts cut targets after the 10 November 2026 report. The fourth-quarter report in early 2027 settles whether the…STXSeagate Technology HoldingsLow Seagate Technology's shares are more likely to lag the S&P 500, because they trade on swinging AI-hardware sentiment while record margins are already reported; Nvidia's 17 November 2026 report and Seagate's late-January fiscal Q2 2027…SVVSavers Value VillageLow Savers Value Village is more likely to lag the S&P 500 over three months: U.S. comparable sales slowed to 5.9% in the third quarter and Ares funds still hold about 65% of the shares. The fourth-quarter report in early 2027 settles whether…SWKSSkyworks SolutionsLow Skyworks Solutions' shares are more likely to lag the S&P 500 over three months: the first combined outlook with Qorvo missed estimates and the $90.03 close sits above most post-report targets. The first full combined quarter, around…SYNASynapticsLow Synaptics' shares trade as a claim on onsemi's $123.00 per share cash offer with no rival bidder left, so they are more likely to trail the S&P 500; the 17 November 2026 shareholder vote and China's antitrust review settle it.SYRESpyre TherapeuticsLow Spyre Therapeutics' shares are more likely to lag the S&P 500 over three months: its three bowel-disease antibodies cleared single-agent trials, but combination data is not due until the third quarter of 2027 and the company keeps issuing…TALTAL Education GroupLow TAL Education's revenue growth slowed to 15.5% in the August 2026 quarter from 31.9% in May, and sales missed estimates, so the shares are more likely to lag the S&P 500; the third-quarter report decides whether growth steadies.TBLATaboola.comLow Taboola's profit grew in Q3, but a second full-year guidance cut on 4 November 2026 broke the recovery case; the shares closed at $2.02 on 10 November 2026. The Q4 report, expected around February 2027, tests the $204.5–213.5 million…TDUPThredUpLow ThredUp's shares are more likely to lag the S&P 500 over three months: on 4 November 2026 the company cut fourth-quarter revenue guidance to $77.0–79.0 million from $85.0–87.0 million, and the fourth-quarter report, expected around…TEAMAtlassianLow Atlassian's shares look more likely to lag the S&P 500 after its 5 November 2026 outlook called for cloud growth to slow to about 27% and seven brokers cut targets; the fiscal second-quarter report, estimated for about 4 February 2027,…TECHBio-TechneLow Bio-Techne's shares are more likely to lag the S&P 500 over three months: they sit just under Merck KGaA's $73.00 cash offer, which caps the gain. Receipt of the remaining regulatory approvals, guided for late 2026 or early 2027, settles…TENXTenax TherapeuticsLow Tenax Therapeutics is more likely to lag the S&P 500 over three months: its recovery needs the FDA to accept an enriched LEVEL-2 trial of TNX-103 after LEVEL failed. The undated Type C meeting outcome settles it.TERTeradyneLow Teradyne's shares are more likely to lag the S&P 500 over the next three months because its chip-test revenue has flattened near $1.3 billion a quarter. Nvidia's 17 November 2026 report and Teradyne's late-January results show whether 2027…THTarget HospitalityLow Target Hospitality's Q3 2026 report showed data-center housing revenue has started, but unchanged guidance and heavier borrowing left the shares at $10.30 on 10 November 2026; fourth-quarter results and sponsor selling settle the case.TITNTitan MachineryLow Titan Machinery's shares, up 26.9% in three months, are more likely to lag the S&P 500 than lead it until results show a farm-equipment recovery; the 24 November 2026 fiscal third-quarter report must show inventory below $931.5 million.TKNOAlpha TeknovaLow Alpha Teknova's third-quarter revenue rose 22% and it raised 2026 guidance to $46-48 million, but the shares at $8.55 already sit near the $8.75 consensus target; 2027 guidance due with full-year results in early 2027 decides the next move.TLRYTilray BrandsLow Tilray Brands has narrowed its fiscal 2027 adjusted EBITDA target to $70–75 million and announced about $30 million of planned annual savings, but the shares still trade near $2.65 and second-quarter results around 8 January 2027 decide…TLYSTilly'sLow Tilly's earnings recovery and above-consensus third-quarter guidance are largely priced out of the shares, which are more likely to lag the S&P 500; the 2 December 2026 third-quarter report settles whether sales reach guidance.TMCTMC the metalsLow TMC the metals company's nodule case hinges on NOAA certifying its USA-A application, which NOAA estimates for mid-December 2026; with no revenue and cash falling, the shares are more likely to lag the S&P 500 over three months until that…TNETTrinet GroupLow TriNet Group's profit recovery is intact (89% insurance cost ratio, 2026 adjusted earnings guidance raised to $5.10 a share), but worksite employees fell 11%, so the shares are more likely to lag the S&P 500 over three months;…TNGXTango TherapeuticsLow Tango Therapeutics' pancreatic-cancer combination is active, but the shares are more likely to lag the S&P 500 over three months: the 23 October 2026 ESMO update (82% response in 22 patients versus 92% in 12) did not extend June's result.…TRIPTripAdvisorLow Tripadvisor's shares are more likely to lag the S&P 500 over three months: third-quarter revenue fell 11%, both segments shrank and the CEO and CFO are leaving. Use of the $741.0 million TheFork proceeds and the CFO's 31 December 2026 exit…TRMDTORMLow TORM plc's shares are more likely to trail the S&P 500 over three months: they closed at $35.36 on 11 November 2026, below the $39.60 net asset value, despite a strong third quarter. LR2 freight rates and Gulf product flows settle it.TSATTelesatLow Telesat's shares are more likely to lag the S&P 500 over three months: unresolved debt on its older geostationary satellites overshadows the Lightspeed low-Earth-orbit build, and a rescue or Chapter 11 filing would likely dilute holders.…TSEMTower SemiconductorLow Tower Semiconductor's shares are more likely to lag the S&P 500 over three months: they closed at $157.86 on 12 November 2026, 40.5% below three months earlier, despite record results. The fourth-quarter report, expected around February…TSHATaysha Gene TherapiesLow Taysha Gene Therapies' Rett syndrome therapy TSHA-102 is more likely to lag the S&P 500 over three months; pivotal six-month interim data and FDA feedback on the filing route, guided to the first half of 2027, settle it.TSSITSSLow TSS, Inc. passed its third-quarter test: record AI rack integration revenue of $16.1 million and a raised profit outlook. The shares still closed at $6.96 on 10 November, so fourth-quarter integration revenue now has to prove the recovery.TTANServiceTitanLow ServiceTitan grows revenue above 20% with widening margins, but slowing transaction volume and a lower third-quarter guide leave the shares more likely to lag the S&P 500; the 3 December 2026 report settles it.TWLOTwilioLow Twilio's fourth-quarter guide of 11–12% organic growth, down from 16% in Q3, has reset the shares, which are more likely to lag the S&P 500 until the Q4 report, estimated for 11 February 2027, shows whether that guide is conservative.UCTTUltra Clean HoldingsLow Ultra Clean Holdings, a gas delivery and process module supplier to chip-equipment makers, is more likely to lag the S&P 500 over three months: record sales have not become cash and equity sales continue. The fourth-quarter report,…UGPUltrapar ParticipacoesLow Ultrapar's shares are more likely to lag the S&P 500: its 11 November 2026 third-quarter report showed recurring EBITDA down 15% from the second quarter and net debt up to R$11.0 billion. The fourth-quarter Ipiranga fuel margin decides…ULBIUltralifeLow Ultralife Corporation trades as a capped claim on EnerSys's $16.00-per-share cash offer, so it is more likely to lag the S&P 500 than lead it; US and UK clearances and the tender, first due to expire on 3 December 2026, settle whether…UMCUnited MicroelectronicLow United Microelectronics is more likely to lag the S&P 500 over three months: it delivered its guided 34% third-quarter margin, but fourth-quarter margin is guided flat. November net sales, due by 10 December 2026, decide the next read.UNITUniti GroupLow Uniti Group's third-quarter report on 9 November 2026 missed on revenue and earnings and widened the guided FY2026 net loss to $590-620 million, so the shares remain more likely to lag the S&P 500 than lead it. The $4.20 close on 10…URGNUroGen PharmaLow UroGen Pharma's ZUSDURI bladder-cancer launch is growing but slowing, and the shares are more likely to lag the S&P 500 over three months. Fourth-quarter ZUSDURI revenue, expected in early 2027, settles whether growth of 35% in the third…UROYUranium RoyaltyLow Uranium Royalty Corp. is more likely to lag the S&P 500 over three months: earnings came from one-off uranium-inventory sales, and a $40.0 million bridge loan falls due 31 January 2027. The fiscal second-quarter report, expected around…UTZUtz BrandsLow Utz Brands shares are more likely to lag the S&P 500 because stockholders approved Intersnack's $14.25 cash take-private on 13 November 2026 and the shares already close there; the closing expected on or around 20 November 2026 settles it.UUUUEnergy FuelsLow Energy Fuels' rare-earth expansion is more likely to lag the S&P 500 over three months after the 4 November 2026 revenue miss and a heavy rare-earth delay to early 2028; the Donald financing decision targeted by 31 December 2026 settles it.VCYTVeracyteLow Veracyte's profitable test business was repriced after its 4 November 2026 report showed Decipher prostate growth of 12% and a mid-single-digit 2027 revenue preview. The fourth-quarter Decipher volume report decides whether growth has…VECOVeeco InstrumentsLow Veeco Instruments' pending Axcelis merger now closes by end of Q1 2027, not 2026, and Q3 earnings missed estimates; China's SAMR ruling and the Q4 revenue guide of $230–260 million settle the case.VERIVeritoneLow Veritone's $45.58 million of convertible notes mature on 15 November 2026, and the company moved its third-quarter report to 16 November 2026 to give "material updates" on debt talks, so the shares are more likely to lag the S&P 500. A…VERULow Veru's case rests on whether its oral drug enobosarm preserves lean mass alongside semaglutide; the PLATEAU 32-week interim, guided to calendar Q1 2027, settles it, while going-concern doubt and an open stock-sale program cap the shares.VETVermilion EnergyLow Vermilion Energy's shares are more likely to lag the S&P 500 over three months: third-quarter free cash flow fell to C$90.5 million from C$122 million, and spending rises in 2027. The fourth-quarter 2026 report, expected around 3 March…VICRVicorLow Vicor Corporation's patent royalties lifted third-quarter revenue to $197.1 million, but guidance implies a lower fourth quarter and the shares are more likely to lag the S&P 500; the late-February 2027 report settles whether royalties…VIOTViomi TechnologyLow Viomi Technology's ADSs have bounced from their late-October low, but sales have not recovered: first-half 2026 revenue fell 49.9%. Second-half results, estimated for around 25 March 2027, must show revenue above RMB740.0 million and a…VLOValero EnergyLow Valero Energy's shares are more likely to lag the S&P 500 over the next three months as refining margins fade from a record third quarter, a case a 4.1 million-barrel U.S. diesel stock build reported on 12 November 2026 supports. The…VMIValmont IndustriesLow Valmont Industries' shares are more likely to lag the S&P 500 over three months: they sit below their 50-day and 200-day averages despite raised guidance, and the fourth-quarter report around 18 February 2027 settles steel and zinc cost…VORVor BiopharmaLow Vor Biopharma's telitacicept case is more likely to lag the S&P 500 over three months: the global myasthenia gravis trial reads out in the first half of 2027, and the 12 November 2026 RC298 deal and a $150 million share filing add dilution…VOYGVoyager TechnologiesLow Voyager Technologies is more likely to lag the S&P 500 over three months: record bookings and a $742 million backlog sit against widening losses, and the shares closed at $27.79 on 12 November 2026, 47.0% below the 52-week high. NASA's 8…VRAVera BradleyLow Vera Bradley's shares look ahead of its results after a 134.5% three-month rise on one tariff-refund-aided quarter; the fiscal third-quarter report, listed for 10 December 2026, shows whether direct sales hold once refunds end.VREXVarex ImagingLow Varex Imaging is a deal-completion case capped at Teledyne's $18.90 cash price; the UK and US reviews ending 18 November 2026 and 19 November 2026 decide whether completion in early 2027 stays on track.VRNSVaronis SystemsLow Varonis Systems is a pending $49.75-per-share cash acquisition by Proofpoint, and the 10 November 2026 close of $49.10 sits below the offer, so upside is capped unless a rival bid appears. Stockholder approval and regulatory clearance,…VSTMVerastemLow Verastem's shares look more likely to lag the S&P 500: its KRAS G12D drug VS-7375 is funded into the first half of 2028, but ovarian revenue missed forecasts and a $100M share program adds supply. The year-end 2026 Phase 3 start and…WDCWestern DigitalLow Western Digital is more likely to lag the S&P 500 than lead it while fears of curbs on AI data centers outweigh its strong December-quarter guide. Nvidia's 17 November 2026 report and late-January 2027 results settle whether the $5.0–5.2…WEYSWeyco GroupLow Weyco Group's 2026 earnings jump leans on tariff refunds that are nearly used up, so the shares look more likely to lag the S&P 500 over three months; the fourth-quarter report, estimated for around 3 March 2027, shows margins without…WITWiproLow Wipro's ADR is more likely to lag the S&P 500 over three months: revenue is flat, December-quarter guidance spans –1.5% to +0.5%, and large-deal bookings fell 58.6%. The mid-January 2027 report shows whether two delayed large deals revive…WIXWix.comLow Wix.com's shares are more likely to lag the S&P 500 because its 10 November 2026 report cut the cash flow margin guide to about 16% and showed bookings slowing to 11%, even as Base44 reached a 58% gross margin. The fourth-quarter report…WKWorkivaLow Workiva's shares are more likely to lag the S&P 500: net retention slipped to 110%, billings growth slowed to 10% and the Q4 revenue guide trails estimates. The February 2027 report and 2027 outlook settle whether growth recovers.WLFCWillis Lease FinanceLow Willis Lease Finance, an aircraft-engine lessor, is more likely to lag the S&P 500 over three months: record lease rent of $84.4 million is offset by utilization of 83.2% and a 55% profit drop. Fourth-quarter results, expected around March…WNCWabash NationalLow Wabash National's trailer orders have recovered faster than its profits, so the shares look more likely to lag the S&P 500 over three months. Backlog hit $1,198 million at 30 September 2026, yet the company guides to a Q4 adjusted loss of…WOLFWolfspeedLow Wolfspeed's first revenue beat since its Chapter 11 exit and a narrower gross-margin loss are real gains, but cash burn and an unfunded $1.5 billion loan make the shares more likely to lag the S&P 500; the fiscal second-quarter report…WRLDWorld AcceptanceLow World Acceptance's shares are more likely to lag the S&P 500 over three months: the 23 October 2026 report showed delinquency rising to 18.9% and revenue flat at $139.2 million, and the shares have fallen further since. The fiscal…WTWisdomTreeLow WisdomTree's assets fell to $166.85 billion in October despite $1.65 billion of client inflows, so the shares, rebounding to $21.44 on 11 November 2026, are more likely to lag the S&P 500; the November asset report and fourth-quarter…WTIW&T OffshoreLow W&T Offshore is more likely to lag the S&P 500 over three months: fourth-quarter output is guided to 32.0–35.3 MBoe/d from 38.2 in the third quarter, and crude is falling; hurricane season's end on 30 November 2026 and crude decide it.WTTRSelect Water SolutionsLow Select Water Solutions' shares are more likely to lag the S&P 500: the Pilot Water deal adds $900 million of 7.625% debt and higher spending before its earnings show up. The fourth-quarter report, the first with Pilot, settles it.WULFTeraWulfLow TeraWulf's move from bitcoin miner to AI data-centre landlord is a delivery-timing story: the 6 November 2026 report pushed first CB-4 rent from September to Q4, and the first reported CB-4 rent settles it.WYHGLow Wing Yip Food's Nasdaq shares are more likely to lag the S&P 500 over three months: 2025 profit fell, 23 million new shares were issued, and the price has swung with no company news. The third-quarter 2026 report, expected around 14…XENEXenon PharmaceuticalsLow Xenon Pharmaceuticals' shares are more likely to lag the S&P 500 because a December 2026 depression readout under a safety overhang now outweighs its pending epilepsy filing; FDA acceptance, due about 16 November 2026, and that readout…XGNExagenLow Exagen's shares are more likely to lag the S&P 500 after a third quarter with about 2% test-volume growth, a wider loss and a new $150 million shelf; a Medicare coverage ruling or full-year revenue above guidance would test that view.XHGXChange TEC.INCLow XChange TEC.INC's shares trade on an AI-expansion plan with no disclosed First Cycle terms or US spending detail, so they are more likely to lag the S&P 500 over three months; a definitive agreement or the fiscal 2026 annual report settles…XOSLow Xos's third-quarter revenue of $5.5 million missed the $14.7 million estimate and full-year revenue guidance was cut to $25–35 million, so the shares are more likely to lag the S&P 500 than lead it. Hub orders for fourth-quarter delivery…XPLow XP Inc. is more likely to lag the S&P 500 over three months: Brazil's fiscal and rate outlook worsened after Lula's 25 October 2026 win and four brokers cut targets. The 17 November 2026 third-quarter report shows whether inflows held near…XPOFXponential FitnessLow Xponential Fitness's weak third quarter (same-store sales down 7.5%) undercuts the business behind Fund 1's $5.61–$7.00 cash proposal, so the shares are more likely to lag the S&P 500 unless the board's review yields a signed or financed…XRAYDentsply SironaLow Dentsply Sirona's shares are more likely to lag the S&P 500 over three months: the 5 November 2026 report missed estimates and cut fiscal 2026 adjusted EPS guidance to $1.20–$1.30. The fourth-quarter report, expected around 26 February…XRPNArmada Acquisition Corp. IILow Evernorth's shares have fallen to $10.41, near the $10.58 price at which Armada's public holders redeemed, yet still trade above the XRP behind them on DailyCoin's share count. The third-quarter report, due about 16 November 2026, settles…XTLBXTL BiopharmaceuticalsLow XTL Biopharmaceuticals' pivot to psychedelics through Psyga has no reported trial start, and the shares are more likely to lag the S&P 500 over three months. The 20 November 2026 director deadline and any trial disclosure settle the…XXITwenty One CapitalLow Twenty One Capital, a Tether-controlled bitcoin treasury company, still has no signed cash-generating acquisition, so its shares are more likely to lag the S&P 500. The 13 November 2026 third-quarter earnings call shows whether a deal,…YAASYouxin TechnologyLow Youxin Technology is more likely to lag the S&P 500 over three months: the shares closed at $0.78 on 12 November 2026, under Nasdaq's $1.00 minimum bid, and shareholders approved a share-capital expansion and reverse split. The fiscal 2026…YSSYork Space SystemsLow York Space Systems' shares are more likely to lag the S&P 500: the 12 November 2026 report showed backlog of $581.0 million and a $749.7 million goodwill write-down. The fourth-quarter report in March 2027 shows whether backlog rises above…ZBRAZebra TechnologiesLow Zebra Technologies' shares are more likely to lag the S&P 500 because memory costs cut third-quarter gross margin to 45.7% and management expects them to rise into mid-2027. The fourth-quarter report in February 2027 shows whether price…ZENAZenaTechLow ZenaTech's drone-survey revenue is growing fast, but the shares are more likely to lag the S&P 500 over three months: they closed at $0.63 on 12 November 2026 while the company sells stock under a $150 million program. The full…ZSZscalerLow Zscaler's business still tracks guidance, but its shares fell to $194.92 on 10 November 2026 in a market-wide sell-off. The 2 December first-quarter report decides whether revenue beats the $935–939 million guide.ZURAZura BioLow Zura Bio's shares are more likely to lag the S&P 500 over three months: the TibuSHIELD hidradenitis suppurativa trial failed on 9 November 2026 and the company dropped that indication. Only the systemic sclerosis result, due by mid-2027,…